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ABSTRACT 
The role of exercise as a means to modulate renal function in hypertension is unclear.  However, 
prior studies in the laboratory of Dr. Penny Knoblich indicate that exercised female 
spontaneously hypertensive rats (SHR) and Wistar Kyoto (WKY) rats excrete significantly more 
sodium in response to a rise in blood pressure relative to exercised male and sedentary female 
SHR and WKY rats. The purpose of this study was to evaluate the effects of exercise on 
endothelin and endothelin receptor levels in the urine and kidneys of male and female SHR and 
WKY rats, to elucidate potential mechanisms to explain an increase in urinary sodium excretion 
in exercised female SHR and WKY rats as previously described by Dr. Penny Knoblich.  Eighty 
male and female SHR and WKY rats were randomly assigned to an exercise or a sedentary 
control group.  Each rat assigned to the exercise group ran voluntarily on a wire wheel for ten to 
twelve weeks.  After ten to twelve weeks, the urine and kidneys of each exercised and sedentary 
rat was collected.  The urine from each group of rats was pooled and analyzed using an ELISA 
assay to determine the concentration of endothelin-1 (ET-1).  The excised kidneys from each rat 
was examined using Western blot analysis and immunofluorescence microscopy to determine 
the amount and location of ET-1, endothelin-A (ET-A) receptors, and endothelin-B (ET-B) 
receptors within the tissue.  The amount of urinary ET-1 excretion was elevated in female rats 
relative to male rats of the same strain and activity level, with exercised female SHR rats being 
the only exception.  Male and female WKY rats were found to excrete more ET-1 than male and 
female SHR rats.  Exercise had a variable effect on urinary ET-1 excretion levels.  ET-A receptor 
levels were increased in kidney lysate of SHR rats when compared to WKY rats and in male rats 
relative to female rats of the same strain and activity level, with exercised male SHR rats being 
the only exception.  Exercise had a variable effect on renal ET-A receptor expression.  ET-B 
receptors were detectable in the kidney lysate of exercised female SHR rats, but not observed in 
any other group of rats.  Immunofluorescence microscopy revealed that ET-A and ET-B receptor 
staining was very broad and localized in most components of the nephron.  However, while ET-A 
receptor staining was observed in each group of rats, ET-B receptors were only detected in renal 
tissue extracted from exercised female SHR rats.  ET-1 receptors were undetectable in the 
kidney tissue of each group of rats using Western blot analysis and immunofluorescence 
microscopy.   An upregulation of ET-B receptors in the kidney tissue of exercised female SHR rats 
may explain previous reports that these rats excrete more sodium in response to a rise in blood 
pressure relative to other experimental groups of rats.  An increase in ET-B receptor expression 
was not observed in the renal tissue of exercised female WKY rats.  However, exercised female 
WKY rats excreted the greatest amount of ET-1 in their urine, which may be responsible for their 
previously reported increase in urinary sodium excretion in response to a rise in blood pressure. 
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INTRODUCTION 
Cardiovascular Physiology and Hypertension 
 Hypertension, a medical condition in which the blood exerts an excessive 
amount of hydrostatic pressure against the walls of blood vessels, is an emerging 
epidemic which affects approximately one in three adults in the United States, more 
than 1 billion people worldwide (1).  The complications associated with high blood 
pressure often lead to potentially fatal conditions of the brain and heart, including 
stroke, heart attack, and congestive heart failure (2).  The blood pressure of a healthy 
adult should be equal to or less than 120 mm Hg systolic and 80 mm Hg diastolic.  With 
every 20/10 mm Hg increase in blood pressure as low as 115/75 mm Hg, the rate of 
mortality from cardiovascular disease doubles (1).  Hypertension is reported to be the 
underlying cause of 39% of heart failure cases in men and 59% of cases in women (3).  
Given this information, it is evident that blood pressure strongly affects the 
cardiovascular system and therefore plays a large role in shaping an individual’s overall 
health. 
Cardiovascular Regulation of Mean Arterial Pressure 
 The pressure of blood flow through the body, also known as mean arterial 
pressure, is regulated by a very complex process (Figure 1).  However, the determinants 
of blood pressure can be simplified and approximated by Ohm’s law modified for fluid 
dynamics (pressure = flow x resistance) (4).  Mean arterial blood pressure is defined as 
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the average arterial blood pressure during a single cardiac cycle and is determined by 
the cardiac output and total peripheral resistance of the cardiovascular system (5). 
 Cardiac output, which is defined as the amount of blood pumped from the 
ventricle per minute, depends on the number of heart beats per minute (heart rate) and 
the volume of blood ejected from the heart per beat (stroke volume) (4; 6).  The human 
heart beating rate, normally ranging from 60 to 100 beats per minute, is determined by 
the speed at which pacemaker cells located in the sinoatrial node of the heart 
spontaneously depolarize to threshold level (4; 6; 7).  An intrinsic heart rate can be 
increased by activating the sympathetic autonomic nervous system and decreased by 
activating the parasympathetic autonomic nervous system.  Stroke volume, the 
difference between the ventricular end diastolic blood volume and the end systolic 
blood volume, is influenced by venous return of blood to the heart from the respiratory 
and skeletal systems (4; 6; 7).  According to the Frank-Starling principle, a larger venous 
return increases the end diastolic blood volume, which stretches the muscle fibers of 
the heart, strengthens the force of ventricular contraction, and results in more blood 
being ejected and an increase in stroke volume (4).  An increase in heart rate or stroke 
volume will result in an increase in cardiac output, and therefore an increase in mean 
arterial blood pressure (4). 
The total peripheral vascular resistance refers to the resistance of blood vessels, 
specifically arterioles, to the flow of blood.  Arterioles are smaller in diameter, have 
thicker muscular walls, and are less elastic than other vessels in the cardiovascular 
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system (4; 6; 7). The muscular walls of arterioles allow for the diameter of the vessels to 
actively change and therefore, regulate peripheral blood flow through the body.  The 
radius of arteriolar walls is regulated extrinsically by the endocrine system and the 
autonomic sympathetic nervous system and intrinsically via metabolic control (4; 8).  
Epinephrine, a component of the endocrine system, is released by the adrenal medulla 
gland in response to stress and binds to arteriolar α receptors (8).  The sympathetic 
nervous system regulates arterioles by norepinephrine binding to receptors on the 
smooth muscles of arterioles (8).  An increase in circulating levels of epinephrine and 
norepinephrine in the body leads to vasoconstriction, while a decrease leads to 
vasodilation of arteriolar walls (4; 8).  The presence of metabolites, such as carbon 
dioxide and potassium, and signaling molecules such as nitric oxide (NO), in the body 
also affects arteriolar blood flow (4).  An increase in these chemicals stimulates the 
vasodilation of local arterioles and the resulting increase in blood flow gradually lowers 
the level of these molecules in the tissue, which triggers arterioles to return to their 
original diameter (4).  Overall, a decrease of blood flow caused by the constriction of 
arterioles generally leads to an increase in mean arterial pressure, whereas an increase 
of blood flow caused by dilation of arterioles is accompanied by a decrease in mean 
arterial pressure (4; 6; 7). 
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Figure 1.  Determinants of Mean Arterial Blood Pressure.  A summary of the factors 
that affect mean arterial pressure (9). 
 
The Effect of Hypertension on the Cardiovascular System 
 Untreated and prolonged elevation of blood pressure leads to changes in the 
myocardial structure, vasculature, and conduction system of the heart (4).  These 
modifications of the cardiovascular system may lead to several heart diseases, including 
left ventricular hypertrophy, coronary artery disease, cardiac arrhythmias, and 
congestive heart failure (4). 
 Left ventricular hypertrophy, the enlargement of the muscle tissue in the wall of 
the left ventricle, is observed in 15-20% of patients with hypertension (10).  Left 
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ventricular hypertrophy usually develops in response to increased blood pressure, which 
increases the work of the left ventricle, and eventually leads to the development of 
myocardial dysfunction (10).   
Patients with untreated hypertension are susceptible to artery damage because 
elevated blood pressure places additional force against arterial walls, leading to the 
narrowing and plaque buildup associated with atherosclerosis (4).  Atherosclerotic 
arterial damage prevents blood flow and oxygen delivery throughout the body, and may 
cause coronary artery disease, the leading cause of death in the United States for men 
and women (4).  
 Several cardiac arrhythmias, including premature ventricular contractions and 
ventricular tachycardia, an abnormally rapid heart rhythm that originates in the 
ventricles of the heart, are commonly noted in patients with high blood pressure (11).  
However, atrial fibrillation, the irregular and chaotic beating of the atria of the heart, is 
the most frequently observed arrhythmia seen in hypertensive patients.  In fact, 
elevated blood pressure is the most common cause of atrial fibrillation in the Western 
hemisphere (11).  Although the connection between hypertension and atrial fibrillation 
is unclear, structural and functional defects of the left atrium may be contributing 
factors (11).   
 Congestive heart failure, the inability of the heart to pump an adequate amount 
of blood to the body, is also a common complication seen in patients with chronically 
elevated blood pressure (12). The development of congestive heart failure in 
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hypertensive individuals can be attributed to several factors, including coexistent 
coronary artery disease and left ventricular hypertrophy (12).  According to the 
Framingham Study, hypertension accounts for about 25 percent of all heart failure cases 
and as much as 68 percent in elderly patients (13).  Hypertensive women and men have 
a two-fold and three fold increased risk, respectively, of developing congestive heart 
failure (12).   
Renal Physiology and Hypertension  
The kidneys play a key role in the regulation of blood pressure by indirectly 
controlling the amount of blood in the body. The kidneys regulate electrolytes, such as 
sodium and potassium, and maintain fluid levels in the body (6; 7) .  The kidneys also 
directly control blood pressure by regulating hormones secreted from both the 
hypothalamus and adrenal gland (6; 7).  In addition to having detrimental effects on the 
cardiovascular system, high blood pressure is also one of the leading causes of kidney 
damage and may lead to kidney failure.  In fact, it has been reported that hypertension 
causes more than 25,000 new cases of kidney failure in the United States every year (1).  
In order to understand the effect of hypertension on the kidneys, it is important to 
consider the structure and function of the renal system. 
 The human renal system consists of two bean-shaped kidneys located on the 
posterior wall of the abdominal cavity, with one on each side of the vertebral column, as 
well as two ureters, a urinary bladder, and the urethra (14; 15) (Figure 2).  The kidneys 
filter blood and produce urine, which is then transported by the ureter to the urinary 
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bladder, where it is stored until it is excreted from the body via the urethra (14; 15).  
Kidney tissue is divided into two distinct regions, the inner renal medulla and the outer 
renal cortex, which in humans, contains more than one million nephrons (14; 15).  A 
nephron, the functional unit of the kidney, is divided into two parts, the renal corpuscle 
and the renal tubule (14; 15).  The renal corpuscle is responsible for filtering blood 
plasma and has two parts, the glomerulus, a network of capillaries, and the Bowman’s 
capsule, an epithelial cup within which the glomerulus is contained (14; 15).  The 
glomerular capillaries are located between the afferent arteriole, which brings blood to 
the glomerulus, and the efferent arteriole, which branches into peritubular capillaries 
that wrap around the nephron and drain blood away from the glomerulus (14; 15).  
Blood from the afferent arteriole is forced into the glomerulus and either filtered into 
the Bowman’s capsule or travels out of the kidney via the efferent arteriole (14; 15).  
The renal tubule, which consists of the proximal tubule, loop of Henle, distal tubule, and 
collecting duct, is responsible for adjusting the water and ion composition of the 
glomerular filtrate (14; 15). 
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Figure 2.  Renal Physiology.  Structure of the kidney and nephron (14). 
 
Renal Regulation of Blood Volume   
 The formation of urine and regulation of the composition and volume of blood 
by the renal system involves three physiological processes known as glomerular 
filtration, tubular reabsorption, and tubular secretion (14; 15) (Figure 3).  Urine 
formation begins with the process of glomerular filtration, which is driven by pressure 
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generated by the beating heart (14; 15).  Glomerular filtration takes place in the renal 
corpuscle of the nephron and involves the nonselective movement of water, waste 
products, ions, and solutes from the blood into the Bowman’s capsule (14; 15).  The 
substance that exits the blood, collectively known as glomerular filtrate, consists 
primarily of water, salts, glucose, and urea (14; 15).  After the glomerular filtrate has 
been formed, it passes from the Bowman’s capsule to the renal tubule, where tubular 
reabsorption takes place (14; 15).  The process of tubular reabsorption returns 
approximately 99% of the glomerular filtrate to the blood via diffusion and active 
transport of ions and solutes, and osmosis of water from the renal tubules into the 
peritubular capillaries. 
(14; 15).  The proximal tubule is responsible for reabsorbing approximately 80% of the 
glomerular filtrate, while the remaining water, salts, and urea are reabsorbed in the 
loop of Henle and the distal tubule (14; 15).  The final step of urine formation, tubular 
secretion, actively transports excess amounts of hydrogen ions, potassium ions, urea, 
and other solutes that are potentially harmful to the body back into the filtrate 
contained in the renal tubules so that they may be excreted in the urine (14; 15).  
 The concentration of solutes in the urine relies on the different permeability 
properties of the two limbs of the loop of Henle (14; 15).  The descending loop of Henle 
is permeable to water but not permeable to salt (14; 15).  Therefore, water gradually 
moves from the descending limb into the interstitial fluid surrounding the nephron, 
which results in more concentrated filtrate (14; 15).  The ascending loop of Henle is 
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permeable to salt but impermeable to water (14; 15).  As sodium and chloride ions are 
transported out of the ascending limb, a concentration gradient is formed, with the 
saltiest interstitial fluid located in the deepest part of the renal medulla (14; 15).  The 
transport of salt into the interstitial fluid also causes the filtrate to become less 
concentrated than normal body fluid (14; 15).  The distal tubule then delivers the filtrate 
to the collecting duct, which passes deep into the renal medulla (14; 15).  The collecting 
duct is highly permeable to urea and therefore, the filtrate loses urea to the surrounding 
interstitial fluid, allowing additional concentration (14; 15).  As urine then passes 
through the collecting duct, water is reabsorbed into the salty interstitial fluid by 
osmosis, which in turn increases the concentration of solutes and waste excreted in the 
urine (14; 15).  In general, dilute urine results in less water in the blood due to osmosis, 
a lower blood volume, and therefore a decrease in mean arterial blood  
pressure (14; 15). 
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Figure 3.  Nephron Regulation of Urine Concentration.  The physiological process  
responsible for the regulation of urine formation and concentration (14). 
 
 
Pressure Natriuresis Relationship and Regulation 
 The long term control of mean arterial blood pressure is linked to the kidney’s 
intrinsic ability to maintain normal sodium levels, extracellular fluid volume, and blood 
volume (16).  Pressure natriuresis and diuresis, which respectively increase sodium 
excretion and urine volume in response to increased renal perfusion pressure (RPP), 
play an important role in the feedback system that regulates arterial pressure (16).  The 
intrarenal mechanisms behind pressure natriuresis and diuresis appear to be related to 
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increased hemodynamic factors such as medullary blood flow (MBF), renal interstitial 
hydrostatic pressure (RIHP), and renal chemical transmitters such as NO (17). 
 The impact of MBF on long-term blood pressure control is believed to be 
mediated by its impact on renal sodium and water handling. The role of MBF in the 
regulation of salt and water excretion was elucidated by studies completed by Cowley 
and colleagues (18).  These experiments demonstrated that reduced MBF increased 
sodium reabsorption and lead to the development of hypertension and that enhanced 
MBF has the opposite effect on renal sodium handling and attenuates hypertension in 
SHR rats (18).   
 Scientists have also proposed that an elevation in MBF, due to an increase in 
RPP, is transmitted into the renal medullary interstitium and leads to a rise in medullary 
interstitial hydrostatic pressure (16; 19).  Due to renal encapsulation, an increase in 
interstitial hydrostatic pressure in the medulla leads to higher interstitial hydrostatic 
pressure throughout the entire kidney (16).  The resulting increase in RIHP is believed to 
inhibit renal sodium reabsorption (20).  Therefore, a direct causal link is postulated to 
exist between increases in RPP, MBF, RIHP, and the amount of sodium excreted in the 
urine.  Studies by Roman and associates have confirmed that increased renal papillary 
blood flow resulting from elevated RPP is correlated with equivalent increases in 
medullary capillary pressure, RIHP, and natriuresis (21). 
 There are two possible mechanisms that may explain the process by which an 
increase in RIHP impairs tubular sodium retention (18; 22). The first mechanism states 
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that an increase in interstitial pressure reduces the movement of sodium and water 
from the tubular fluid to the capillaries, thereby elevating the amount of sodium 
excreted in the urine (18; 22).  The second mechanism suggests that an increase in RIHP 
drives water into the descending loop of Henle, which lowers water retention and 
sodium reabsorption and produces a dilute filtrate (18; 22).  The decrease in sodium 
reabsorption is thought to be facilitated by increased levels of nitric oxide in the 
endothelium (23). 
 Nitric oxide, known for its potent vasodilation properties, is believed to play an 
important role in the regulation of urinary sodium excretion through mechanisms 
involving effects on renal blood flow, glomerular filtration rate, and direct tubular 
actions (16; 24).  Several investigators have demonstrated that the acute or chronic 
inhibition of NO synthesis via oral administration of nitric oxide synthase inhibitors 
results in arterial hypertension and a markedly suppressed pressure natriuresis and 
diuresis response in animals (23; 25; 26).  Studies have also reported that increased 
intrarenal NO levels and urinary excretion of NO metabolites correlates with an increase 
in RPP in dogs (25).  The production of NO, caused by an increase in arterial shear stress 
due to elevated mean arterial pressure and renal blood flow, increases natriuresis by 
directly inhibiting tubular sodium reabsorption and transport in the kidney (23; 27).  A 
recent study by Nakano and colleagues has shown that increased sodium and water 
excretion associated with elevated levels of NO is linked to an upregulation of renal 
endothelin and endothelin-B receptor levels (28). 
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Hormonal Control of Mean Arterial Pressure 
 In addition to regulating blood pressure and urine concentration with intrinsic 
mechanisms of the nephron, sodium and water handling in the renal tubules is 
controlled by hormones excreted from the adrenal gland and the hypothalamus.  
Aldosterone, a steroid hormone produced by the adrenal cortex of the adrenal gland, 
causes tubular sodium retention, which leads to an increase in blood pressure (29; 30).  
The release of aldosterone is controlled via the renin-angiotensin-aldosterone system 
(RAAS), which can be triggered by a decrease in blood volume or a lack of sodium 
delivery to the distal tubules of the kidney (29; 30) (Figure 4).  Activation of the RAAS is 
initiated by the regulated secretion of renin from the juxtaglomerular cells in the 
kidneys.  Angiotensinogen, a protein secreted by the liver into the blood, is converted 
into angiotensin I by renin (29; 30).  Another enzyme, angiotensin converting enzyme 
(ACE), subsequently converts angiotensin I into angiotensin II, which causes blood 
vessels to contract and stimulates the release of aldosterone from the adrenal gland and 
vasopressin from the pituitary gland (29; 30).  Aldosterone increases the activity of 
sodium-potassium pumps, which causes the distal tubule and collecting duct to increase 
the reabsorption of sodium (29; 30).  Due to osmosis, the reabsorption of water into the 
renal tubules also increases, which increases the volume of blood and therefore the 
mean arterial blood pressure (29; 30).  Vasopressin controls the reabsorption of water 
molecules in the renal tubules of the kidneys by increasing the permeability of the distal 
tubules and collecting ducts to water (29; 30).  As a result, more water diffuses out of 
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the filtrate and is absorbed by blood in the peritubular capillaries, which decreases the 
amount of water excreted in the urine and increases the mean arterial blood  
pressure (29; 30).   
  In contrast to aldosterone and vasopressin, atrial natriuretic peptide (ANP) is a 
hormone that increases urinary sodium excretion (8).  ANP is released by muscle cells in 
the atria of the heart in response to stretch of the atrial walls due to a high blood 
volume (8).  Once released from the atria, ANP directly inhibits aldosterone by 
preventing its secretion from the adrenal cortex and indirectly inhibits the RAAS by 
impeding renin secretion from the kidneys, which leads to a decrease in mean arterial 
blood pressure (8).  
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Figure 4.  RAAS System.  The mechanism and effect of the RAAS system on renal 
function (30). 
 
 
The Effect of Hypertension on the Renal System 
Chronic high blood pressure, if left untreated, may damage the blood vessels of 
the renal system. In fact, hypertension is the number two cause of chronic kidney 
disease (1).  If the blood vessels of the kidneys are impaired, the process of removing 
waste and excess fluid from the body may cease.  Persistant impairment may lead to the 
development of kidney damage, such as kidney scarring, kidney artery aneurysm, or 
kidney failure (4; 15).   
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Types of Hypertension 
 Hypertension may be classified as primary or secondary depending upon the 
etiology of the increase in blood pressure (31).  Primary hypertension, which accounts 
for approximately 95% of all cases, has no identifiable cause, but tends to gradually 
develop with age and appears to be the result of an interaction of environmental and 
genetic factors (31).  Some factors that are believed to play a role in the development of 
primary hypertension are obesity or sedentary lifestyle, insulin resistance, genetic 
predisposition, high alcohol and sodium consumption, high levels of stress, and low 
potassium and calcium intake (31).  Approximately 5% of hypertension cases are 
classified as secondary hypertension, in which an increase in blood pressure results from 
an underlying, identifiable, and often correctable cause (32).  Several different factors, 
including chronic renal disease, hyper- or hypothyroidism, aortic coarctation, primary 
hyperaldosteronism, and certain pharmaceutical drugs, may lead to the development of 
secondary hypertension (32).   
Mechanisms of Hypertension  
Hypertension is the most common treatable risk factor for several potentially 
fatal diseases, including stroke, congestive heart failure, and renal disease.  Despite the 
harmful effects of elevated mean arterial blood pressure and the wide availability of 
effective treatments, hypertension is only sufficiently controlled in 34% of patients (33).  
Doctors are often unable to effectively lower blood pressure in patients due to the fact 
that so little is known about the mechanisms and molecular pathogenesis of 
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hypertension (33). Thoroughly understanding the pathophysiology of hypertension 
involves the consideration of several factors that influence blood pressure homeostasis, 
including sodium intake, and renal structure and function. 
Sodium Consumption and Hypertension 
High sodium intake is considered one of the major factors in primary blood 
pressure elevation (34).  In fact, primary hypertension is not present in populations 
where sodium chloride intake is less than 50 mmol per day.  Studies in Finland have 
shown that a progressive decrease in salt intake plays an important role in decreasing 
the occurrence of cardiovascular disease and the average blood pressure of the 
population (35).  During the past 30 years, the salt intake in Finland has decreased by 
one-third, which has resulted in a 10 mm Hg fall in the average systolic and diastolic 
blood pressure of the population, and a 75% decrease in stroke and coronary heart 
disease mortality rates (35).  According to the Dietary Approaches to Stop Hypertension 
trial, reducing sodium intake from 150 mmol per day to 100 mmol per day may reduce 
systolic blood pressure by 2.1 mm Hg and reducing sodium intake from 100 mmol per 
day to 50 mmol per day may reduce systolic blood pressure by an additional  
4.6 mm Hg (34). 
Kidney Structure and Function and Hypertension 
The importance of the kidney in hypertension is supported by kidney cross-
transplantation studies in strains of hypertensive rats.  These studies have reported that 
transplanting a kidney from a hypertensive rat leads to elevated blood pressure in a 
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previously healthy rat and, vice versa, that a kidney transplanted from a normotensive 
rat normalizes the blood pressure in a previously hypertensive rat (36). Hypertension is 
believed to be caused by several factors, including abnormalities in kidney structure, 
renal vascular remodeling, a shift in the blood pressure natriuresis relationship, 
inappropriate activation of the RAAS, and over activity of the sympathetic nervous 
system (37).   
Abnormalities in the kidney structure, particularly a reduction in the number of 
glomeruli or in the filtration surface area per glomerulus, limits the ability of the kidney 
to excrete sodium and may result in elevated blood pressure (38).  This hypothesis was 
tested by comparing the number and volume of glomeruli in patients with high blood 
pressure relative to healthy control patients (38). The researchers reported that the 
number of glomeruli was significantly lower, and in an attempt to compensate, the 
volume of each glomeruli was significantly higher in hypertensive individuals (38). 
The remodeling of large and small resistance arteries, an adaptive response to 
long-term changes in hemodynamic conditions, has been reported to contribute to the 
development and complications of hypertension (39).  Patients with mild essential 
hypertension tend to undergo inward eutrophic arterial remodeling, which reduces the 
outer and lumen diameters, does not affect the cross-sectional area of the media, and 
increases the media/lumen ratio (39; 40).  Hypertrophic vascular remodeling, common 
in cases of more severe hypertension, is characterized by excessive media growth that 
encroaches the arterial lumen, thereby increasing the vascular media/lumen  
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ratio (39; 40).  Cell growth, apoptosis, inflammation, and fibrosis are some of the factors 
that are believed to contribute to hypertensive vascular remodeling (39). 
Chronic elevated mean arterial blood pressure causes an abnormal pressure 
natriuresis relationship, in which urinary sodium excretion is consistent with 
normotension despite the elevation in pressure (41; 42) (Figure 5).  The resetting of the 
pressure natriuresis mechanism to higher pressures is essential for the development 
and sustainment of hypertension because if unaltered, sodium excretion levels would 
be increased until arterial pressure returned to its original set point (41; 42).  The 
alteration in renal function responsible for the resetting of the pressure natriuresis 
curve is believed to be caused by several factors, including increased sympathetic 
nervous system and RAAS activity (41; 42).   
             
Figure 5.  The Effect of Hypertension on the Pressure Natriuresis Curve.  Urinary 
sodium excretion of patients with hypertension relative to normotensive patients (43). 
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The RAAS is believed to play a primary role in the pathogenesis of hypertension 
in that angiotensin II affects various physiologic components that regulate mean arterial 
blood pressure (44).  The release of angiotensin II causes aldosterone secretion, vascular 
hypertrophy, vasoconstriction, and a decrease in the vasodilatory effects of nitric oxide.  
Therefore, an overactive RAAS could lead to the development of hypertension (44). 
Recent studies have postulated that an increase in proximal tubule angiotensin II 
receptors, which leads to an increase in sodium retention, may be responsible for the 
development of hypertension (45). In addition, high renin levels observed in patients 
with elevated blood pressure are caused by the defective feedback regulation of RAAS 
within the kidneys and adrenal glands (45).   
Increased sympathetic nervous system activity, which results in elevated 
circulating plasma levels of norepinephrine and epinephrine, has been detected in 
patients with hypertension as well as in experimental hypertensive animal models (46).  
An increase in these neurotransmitter levels is thought to raise mean arterial blood 
pressure by impairing the ability of the kidneys to effectively excrete sodium and water 
from the body (46).  Overactive sympathetic activity results in several effects that may 
lead to the development of hypertension, such as increased tubular sodium 
reabsorption, vasoconstriction, renal vascular resistance, and angiotensin II production 
(46).   
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Endothelin System and Hypertension 
 The human endothelin proteins, a gene family that consists of endothelin-1 
(ET-1), endothelin-2 (ET-2), and endothelin-3 (ET-3), play an important role in regulating 
vascular tone and renal homeostasis through antagonistic vasoactive effects (47; 48).  
ET-1, the most prevalent member of the endothelin family, is synthesized in endothelial 
cells and inner medullary collecting ducts in response to growth factors such as 
thrombin, transforming growth factor β, and insulin, and to vasoactive substances such 
as angiotensin II, norepinephrine, and ADH (48).  The release of ET-1 is also stimulated in 
response to low levels of shear stress. In fact, high shear stress is a potent inhibitor of 
ET-1 secretion (49).  
Endothelin-1 Synthesis 
 The biologically active form of ET-1 is produced by a sequence of cleavage steps 
(Figure 6).  Preproendothelin-1 (preproET-1), the 212-amino acid ET-1 precursor, is 
cleaved by a paired basic amino acid cleaving enzyme (50; 51).  This enzymatic step is 
believed to be relatively nonspecific and results in the formation of a 38-amino acid 
intermediate peptide known as big endothelin-1 (BigET-1)(50; 51).  BigEt-1 is cleaved at 
Trp21-Val22 and converted into mature ET-1, a 21-amino acid peptide, by endothelin-
converting enzyme-1 (ECE-1), which is specific for endothelin (51).  ECE-1, an essential 
component of ET-1 processing, has been localized predominantly to human blood vessel 
endothelial cells, which is also the primary source of ET-1 secretion (51).  The expression 
of ECE-1 is mediated by protein kinase C (PKC), ET-B receptors, and cytokines (51). 
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Figure 6.  Biosynthesis of Endothelin-1.  The pathway of vascular endothelin-1  
synthesis (52). 
 
 
Endothelin-1 and the Regulation of Mean Arterial Pressure 
  The presence of a vasoconstrictor peptide secreted by endothelial cells was 
discovered in 1985, but ET-1 was not isolated and cloned until 1988 (53).  The 
vasoconstricting ability of ET-1 has never been disputed; in fact, it remains the most 
potent vasoconstrictor found to date.  However, ET-1 has also been determined to have 
other effects on the vasculature, including vasodilation.  
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The biological effects of ET-1 are regulated by two plasma-membrane-bound 
receptors, endothelin-A (ET-A) receptor and endothelin-B (ET-B) receptor, both of which 
bind to ET-1 with equal affinity (51; 54).  The ET-A and ET-B receptors exhibit sequence 
similarity, sharing about 63% of amino acid identity and have a high degree of sequence 
conservation, about 90%, across mammalian species (51; 54). Both endothelin receptor 
subtypes belong to the rhodopsin superfamily, are characterized by the presence of 
seven trans-membrane segments, and are G-protein coupled (55).   
Endothelin receptors are found in many locations in the body, which explains 
why ET-1 is capable of producing several different physiological responses (Figure 7).  
ET-A receptors are found primarily in the heart and on vascular smooth muscle cells and 
are regarded as mediating vasoconstriction, cell proliferation, apoptosis, and fibrosis 
(56).  Low densities of ET-B receptors, which function similar to ET-A receptors, are also 
present on smooth muscle cells (56). However, ET-B receptors are predominately 
expressed on endothelial cells throughout the human vasculature, especially in the 
human kidney, where they represent approximately 70% of the receptors present in the 
cortex and medulla (56). Upon activation by ET-1, the ET-B receptors located on 
endothelial cells mediate dilation by releasing endothelium-derived vasodilators, such as 
nitric oxide, in a feedback mechanism that limits ET-A induced vasoconstriction (56).   
ET-B receptors also function as a clearing receptor and remove ET-1 from circulation, 
explaining the relatively short ET-1 plasma half-life (56).  Within the renal tubular 
system, ET-A receptors are located in distal tubules and cortical collecting ducts and  
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ET-B receptors are found in epithelial cells of proximal tubules and inner medullary 
collecting ducts (57).  ET-1 derived from endothelial cells of the renal system usually 
binds to ET-A receptors and provokes vasoconstriction, while ET-1 produced in the 
medulla causes vasodilation and sodium excretion via ET-B receptors (58). 
 
 
                         
 
Figure 7.  The Endothelin System.  Interactions of Endothelin-1 with Endothelin-A and 
Endothlelin-B receptors in vascular endothelium and smooth muscle cells (59). 
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The Physiological Effects of Endothelin-A Receptor Binding 
 When ET-1 binds to the ET-A receptor, which is coupled to the G(q)-G11 protein, 
phospholiphase C (PLC) is activated (47; 54) (Figure 8).  This leads to the breakdown of 
phosphatidylinositol 4,5-bisphosphate and the generation of inositol 1,4,5-triphosphate 
(IP3) and diacylglycerol (DG) (47; 54).  The formation of IP3 stimulates the release of 
calcium from intracellular storage sites and facilitates the influx of extracellular calcium 
through voltage-dependent calcium channels (VDC) and receptor-operated calcium 
channels (ROC) (47; 54).  The increase in the total intracellular free calcium level 
regulates various processes, including the activation of cellular contractile machinery 
(47; 54).  The release of DAG stimulates prolonged activation of PKC activity, which, by 
causing phosphorylation of different proteins, could result in either activation or 
inactivation of proteins and the regulation of gene expression (47; 54).   
ET-1 induced activation of ET-A receptors stimulates phospholipase A2 (PLA2), 
which produces prostacyclin (PGL2), prostaglandin E (PGE2), and thromboxane (TXA2) to 
help mediate the contractile response (54).   The binding of ET-1 to ET-A also causes an 
increase in intracellular pH via stimulation of the sarcolemmal Na+H+ antiporter, which 
enhances the sensitivity of myofilaments to calcium and may cause cellular contraction 
without an increase in calcium concentration (47; 54).   
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Figure 8.  Endothelin-A Receptor Binding.  The intracellular signal transduction 
pathways activated by ET-1 binding to ET-A receptors (54). 
 
 
The Physiological Effects of Endothelin-B Receptor Binding 
 Similar to ET-A, the binding of ET-1 to ET-B receptors located in vascular smooth 
muscle cells stimulates vasoconstriction (56).  However, the activation of ET-B receptors 
found in endothelial cells triggers signaling pathways that promote the release of 
vasodilator substances such as NO, PGI2, and endothelium-derived hyperpolarizing 
factors (47).  The signaling of NO production through ET-B receptors is coupled to the 
Gβγ protein, which has been linked to protein kinase B (PKB) phosphorylation of 
endothelial nitric oxide synthase and the upregulation of NO production (47).  NO 
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diffuses into vascular smooth muscle, where it stimulates guanylate cyclase and 
increases the levels of cyclic guanosine monophosphate (cGMP) (47).  The increased 
concentration of cGMP causes vascular smooth muscle relaxation by decreasing 
intracellular calcium concentrations and myofilament sensitivity to calcium (47).  The 
decrease in endothelial calcium stimulates prostacyclin production.  Prostacyclin, a 
potent vasodilator, causes the activation of adenylate cyclase and increases cyclic 
adenosine monophosphate (cAMP), which affects the vascular smooth muscle in the 
same way as cGMP (47).  The activation of ET-B receptors also triggers the release of 
endothelium-derived hyperpolarizing factors, which activate potassium channels and 
cause hyperpolarization, inhibition of calcium influx, and dilation of the vascular smooth 
muscle (47). 
The Pathophysiology of the Endothelin System 
 
 Endothelin appears to be contributory to the development of several diseases, 
including systemic hypertension.  Intravenous injections of endothelin causes a brief 
decrease in blood pressure, due to activation of ET-B receptors, followed by a lengthy 
increase in blood pressure caused by the stimulation of ET-A receptors (51; 54).  It has 
been reported that treatment with an ET-A/ET-B receptor antagonist lowers blood 
pressure in patients with essential hypertension, suggesting that ET-1 may contribute to 
the development and maintenance of hypertension in these subjects (51). 
A significant relationship between the concentration of ET-1 in vascular tissue 
and mean arterial blood pressure has been established in rats with  
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deoxycorticosterone acetate (DOCA)-salt-induced hypertension and in rats with 
hyperinsulinemic hypertension (51; 54).  Studies have shown that elevated blood 
pressure in rats with DOCA-salt-induced hypertension is significantly reduced by ET-A 
receptor antagonists and by an ECE-1 inhibitor (51; 54).  Hyperinsulinemic hypertensive 
rats, which have increased mesenteric ET-1 levels due to high levels of plasma insulin, 
experience a decrease in systemic blood pressure when treated with an ET-A/ET-B 
receptor antagonist without affecting the insulin concentration in the plasma or the  
ET-1 concentration in the mesentery (51; 54).   
Adult mice lacking ET-B receptors have significantly elevated systemic blood 
pressure, which is shown to be salt sensitive and resistant to ET-A receptor antagonists, 
suggesting that ET-B receptors play a natriuretic role in the kidneys (51).  Studies of the 
isolated perfused mouse kidney have shown that ET-1 increases sodium excretion and 
leads to a decrease in mean arterial blood pressure (51).  
Exercise and Hypertension 
 Patients with elevated mean arterial blood pressure are commonly prescribed a 
treatment plan that includes lifestyle modifications and pharmacological interventions.  
However, in studies where only pharmacological management is prescribed only 25% to 
62% of patients achieved normal blood pressure values (60).  Because management of 
blood pressure is difficult with pharmacology, many doctors also recommend lifestyle 
adjustments, such as initiating a regular exercise regime (60).  Regular physical activity, 
such as walking, jogging, cycling, or swimming, has been shown to decrease peripheral 
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arterial and vascular resistance, increase venous capacity, and improve arterial 
compliance and vascular endothelial function thus significantly lowering blood pressure 
in both hypertensive and normotensive patients (61).  Frequent aerobic exercise of 
moderate intensity improves endothelial function in patients with primary 
hypertension.  This leads to a decrease in systolic blood pressure by 6 to 10 mm Hg and 
diastolic pressure by 4 to 8 mm Hg and lowers the risk of cardiovascular mortality and 
morbidity (61; 62).  The Joint National Committee of High Blood Pressure recommends 
that patients with mild to moderate primary hypertension exercise at an intensity of 
approximately 50% of maximum oxygen consumption for 30 minutes, 5 to 7 times per 
week, for at least 10 weeks to see the beneficial effects of physical activity on high blood 
pressure (61). 
Physiological Effects of Exercise  
The mechanism by which exercise improves endothelial function is not entirely 
clear, but is believed to be associated with an increase in nitric oxide production due to 
up regulation of endothelial nitric oxide synthase (eNOS) gene expression, a decrease in 
NO inactivation, and vascular endothelial growth factor induced angiogenesis (62).  
Acetylcholine (Ach), an endothelium-dependent vasodilator, is also found in higher 
concentrations after physical training in hypertensive patients as well as healthy 
individuals (62).  One possible mechanism by which regular aerobic activity raises the 
level of vascular NO and Ach is via an increase in vascular shear stress resulting from 
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increased blood flow (62).  The acute or chronic increase in shear stress is known to 
stimulate the release of NO in isolated vessels and cultured cells.   
A recent study has reported that an increase in shear stress in epicardial 
coronary arteries of dogs after 10 days of treadmill exercise increased the expression of 
the eNOS gene, which caused the Ach stimulated NO release (63).  The effect of exercise 
is also believed to cause a 20% decrease in plasma renin activity, a 29% decrease in the 
concentration of a potent vasoconstrictor, norepinephrine, and a 7.1% decrease in 
vascular resistance after endurance training for at least four weeks (61).  
Exercise and the Endothelin System 
 The effect of chronic exercise training on the function of vascular endothelial 
cells has been documented in humans and rats.  According to recent studies, regular 
aerobic exercise reduces plasma ET-1 levels in human subjects and this reduction may 
prevent vasoconstriction and the progression of hypertension (64).  On the contrary, 
exercise has been documented to have an opposite effect on the renal endothelin 
system in rats (65) .  It has been reported that exercise causes an increase in kidney ET-1 
and a decrease in kidney NO production, both of which contribute to an exercise-
induced decrease in renal blood flow (65).  The same study also noted that the 
magnitude of decrease in renal blood flow during exercise was significantly lessened by 
the administration of an ET-A receptor antagonist (65). 
 Limited information is available on the effect of exercise on endothelin receptor 
expression in rats.  However, an experiment recently conducted on swine has reported 
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that exercise lowers systemic ET-A receptor levels, thereby contributing to metabolic 
vasodilation, and has no effect on ET-B expression (66).   
Spontaneously Hypertensive Rats 
The Spontaneously Hypertensive Rat (SHR) is commonly used in genetic 
hypertension studies because it develops essential hypertension similar to humans (67).  
The SHR strain originated in the 1960s by selective breeding of Wistar-Kyoto (WKY) rats 
with high blood pressure (68).  Relative to WKY rats, SHRs have a reduced kidney and 
body mass, which may be caused by a metabolic irregularity (67). Unlike WKY rats, SHRs 
begin to develop hypertension around 5 weeks of age and may reach systolic pressures 
as high as 180 to 200 mmHg (68).  SHRs are known to undergo an alteration in their 
pressure natriuresis relationship, which requires an increased RPP to excrete a normal 
volume of sodium and water (68) and they also exhibit lower renal nitric oxide synthase 
activity and protein expression relative to normotensive control rats (69). 
The Effects of Exercise on Spontaneously Hypertensive Rats 
 Studies have shown that moderate exercise wheel activity and forced treadmill 
exercise significantly lower the resting mean arterial pressure of young rats of the SHR 
strain (70).  According to research by Overton and associates, SHRs that ran 3-7 
kilometers per day for 12 weeks reduced their resting blood pressure by approximately 
20 mmHg (70).  These findings were confirmed by Edwards, who reported that systolic 
blood pressures in SHRs were significantly decreased in exercise-trained animals relative 
to non-exercised SHR control animals (71).  It is believed that the exercise-induced blood 
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pressure reduction in SHRs may be caused by an increase in endothelial nitric oxide 
formation (72). 
   Rats of the SHR strain tend to engage in less physical activity than WKY rats when 
given access to an exercise wheel.  One possible mechanism explaining this decrease in 
physical activity is that unlike WKY rats, SHRs are unable to increase their aortic 
elasticity or compliance during exercise (73).  SHRs are also reported to have a reduction 
in endothelial function and nitric oxide synthesis, which leads to a decrease in blood 
flow rate and vessel diameter during exercise, relative to WKY rats (74). 
The Endothelin System of Spontaneously Hypertensive Rats 
 Several studies have provided evidence that the endothelin system is involved in 
the pathogenesis and maintenance of hypertension in SHRs.  One such study has 
documented that, because of a reduced capacity of the kidney to synthesize ET-1, the 
mean daily urinary excretion of ET-1 in SHRs is significantly lower than that measured in 
WKY rats (75).  The same study also reported that the outer and inner medulla derived 
from SHRs released less ET-1 relative to WKY rats of the same age (75).  This study 
revealed a decrease in ET-1 excretion and medulla levels in 8-9 week old rats, which is 
the age of high blood pressure development, but not in 3-4 week old rats (75). 
SHR rats tend to have an increased amount of vascular shear stress, which has 
been reported to have a strong effect on the synthesis and expression of endothelin in 
humans (49).  A recent study exposed cultures of human umbilical vein endothelial cells 
to laminar shear stress and found that long-term application of shear stress lead to a 
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down regulation of preproET-1 mRNA, ECE-1 mRNA, and ET-1 protein expression levels 
(49).  This study also reported an upregulation of ET-B receptor protein levels in 
response to long-term arterial shear stress (49). 
 The expression of endothelin receptor subtypes in the kidneys of SHRs has also 
been examined.  ET-A receptors are upregulated in the glomeruli and smooth muscle 
cells of SHRs relative to age-matched WKY rats due to an increase in ET-A receptor 
expression, as shown by an increase in mRNA formation (55).  Similarly, ET-B receptors 
are also upregulated in the glomeruli of SHRs compared to age-matched WKY rats (55).  
However, this increase in receptor density is not caused by an upregulation of ET-B 
mRNA but results from a decrease in ET-B receptor degradation or to inactivation of 
enzymes involved in ET-B receptor degradation (55).  Studies have also shown that 
blocking endothelin receptors in SHR rats with either an ET-A receptor antagonist or an 
ET-A/ET-B receptor antagonist results in a similar decrease in mean arterial blood 
pressure (58).  This suggests that the overexpression of vascular ET-A receptors is 
essential in renal blood flow regulation and contributes to the development of high 
blood pressure in SHRs (58). 
Purpose of Current Study 
Prior studies in the laboratory of Dr. Penny Knoblich have reported a significant 
increase in sodium excretion in exercised female spontaneously hypertensive rats (SHR) 
and Wistar Kyoto (WKY) rats in response to a rise in blood pressure induced by either 
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vessel ligation or angiotensin II infusion.  However, this effect was not observed in 
exercised male and sedentary SHR and WKY rats (76).  
The blood pressure lowering effect of exercise has been established; however it 
is unknown how exercise affects the endothelin system. The purpose of this study was 
to evaluate the effect of exercise on the endothelin system of female SHR and WKY rats. 
The study also included male SHR and WKY rats to confirm that any alterations in the 
measured parameters explained the sex difference previously observed in Dr. Penny 
Knoblich’s laboratory.  Exercised induced changes in endothelin and or endothelin 
receptor levels were analyzed to elucidate potential mechanisms to explain an increase 
in sodium excretion in exercised female SHR and WKY rats as previously described in the 
laboratory of Dr. Penny Knoblich. 
Our experiments were based on three hypotheses.  The first hypothesis states 
that since ET-A receptors function in vasoconstriction, levels of ET-A receptors would be 
down regulated in the kidneys of exercised female SHR and WKY rats relative to 
sedentary female SHR and WKY rats.  It was also hypothesized that there would be no 
change in the expression of ET-A receptors in exercised male SHR and WKY rats relative 
to their sedentary counterpart.  Western blot analysis and immunofluorescence 
microscopy were utilized to evaluate the level of ET-A receptors in the kidneys of each 
group of rats.  Our hypothesis would be supported if ET-A receptor levels were lowest in 
the kidneys of exercised female SHR and WKY rats. 
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ET-B receptors play an important role in vasodilation and the facilitation of 
sodium excretion from the body, therefore the second hypothesis states that ET-B 
receptor levels would be up regulated in the kidneys of exercised female SHR and WKY 
rats relative to sedentary female SHR and WKY rats.  It was also hypothesized that there 
would be no change in the expression of ET-B receptors in exercised male SHR and WKY 
rats relative to their sedentary counterpart.  The expression of ET-B receptors in the 
kidney tissue of each group of rats were evaluated using western blot analysis and 
immunofluorescence microscopy.  If our hypothesis was supported, ET-B receptor levels 
would be highest in kidney tissue extracted from exercised female SHR and WKY rats. 
The third hypothesis states that since ET-1 is required to activate both ET-A and 
ET-B receptors, there would be no significant difference in ET-1 concentration in the 
kidneys of exercised and sedentary female and male rats of either strain. ET-1 levels in 
the kidneys of each group of rats were assessed using western blot analysis, enzyme-
linked immunosorbent assay, and immunofluorescence microscopy.  If ET-1 expression 
levels were similar in the kidney tissue extracted from each group of rats, then our 
hypothesis would be supported. 
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MATERIALS AND METHODS 
Animal Husbandry and Exercise Regime 
Twenty male SHR rats, twenty male WKY rats, twenty female SHR rats, and 
twenty female WKY rats, maintained in the animal care facility at Minnesota State 
University, Mankato, were given ad libitum access to tap water and standard rat chow 
(Purina LabDiet, Brentwood, MO).  The temperature of the colony was kept at a 
constant 21  2o Celsius with a 12:12 night/day light cycle.  At four weeks of age, ten 
rats from each group were randomly assigned to an exercise group and ten rats from 
each group were randomly assigned to a control group.  The rats assigned to the 
exercise group ran voluntarily on wire exercise wheels that measured 28 cm in diameter 
for ten to twelve weeks. A magnet and magnetic counter recorded the number of 
exercise wheel revolutions, and a bicycle odometer was used to record the total 
distance and duration of wheel activity. Data was recorded two times per week, and the 
total weekly distance and duration of activity was calculated for each rat. The control 
group was not exercised and therefore not provided a wire exercise wheel. 
Surgical Procedure 
After ten to twelve weeks post exercise, the exercised and control rats were 
prepared for surgery as follows:  Each rat was placed in a 22.9 cm x 12.7 cm x 10.2 cm 
plastic anesthetic chamber until its bladder was voided.  After urination, the rat was 
removed and the urine was collected using a 1cc sterile syringe and stored at -20o 
Celsius for future analysis.  The rat was returned to the chamber and euthanized using 
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carbon dioxide inhalation for approximately two minutes or until breathing ceased.  The 
body mass to the nearest tenth of a gram was recorded.  An incision was made on the 
ventral midline, from the pubic bone extending to the thorax.  The kidneys were located 
and cut free from surrounding fat tissue. Nylon surgical thread (Coats & Clark, 
Greenville, SC) was then tied around the renal arteries to reduce blood flow to the 
kidneys preceding their excision.  After removal, the kidneys were rinsed in phosphate 
buffered saline (PBS) [(137mM NaCl, 2.7mM KCl, 10mM Na2HPO4, 2mM KH2PO4 (pH 7.4)] 
and mass and overall morphology noted. The kidneys were flash frozen in liquid 
nitrogen and stored at -20o Celsius for future analysis. 
Enzyme-Linked Immunosorbent Assay  
Reagent Preparation  
 
A commercially available Endothelin-1 enzyme-linked immunosorbent assay 
(ELISA) kit (Assay Designs, Ann Arbor, MI) was used. Wash buffer was prepared by 
diluting 50 ml of the supplied wash buffer concentrate with 950 ml of deionized water 
and stored at room temperature.  Endothelin-1 standards were prepared by serial 
dilutions of the supplied 1,000 pg/ml endothelin-1 standard stock solution (Figure 9).  
The endothelin-1 antibody was prepared by diluting 40 µl of the supplied antibody 
concentrate with 4 ml of antibody diluent.  An equal amount of urine from each rat in 
each experimental group, totaling 20 µl per group, was pooled and centrifuged at 4,000 
x gravity for 5 minutes. 
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Figure 9. Preparation of Endothelin-1 standards. The serial dilution scheme used to 
prepare the eight standards needed for the ELISA analysis.  Cartoon adapted and 
modified from the manufacturer supplied literature (Assay Designs, Ann Arbor, MI) 
 
Assay Procedure 
100 µl of the assay buffer was added to the 0 pg/ml standard wells, followed by 
adding 100 µl of standards #1 through #8 and 100 µl of each urine sample from the 8 
groups to the bottom of their respective wells.  The plate was sealed and incubated 
overnight at room temperature.  Following incubation, the wells were washed with 400 
µl of wash buffer five times for five minutes each.  After the final wash, the wells were 
emptied and the plate firmly tapped against a paper towel to ensure all remaining 
buffer was removed.  100 µl of the diluted antibody was added to each well with the 
exception of the blanks, and the plate was sealed and incubated at room temperature 
for one hour.  Following incubation, the wells were emptied and washed with 400 
microliters of wash buffer five times for five minutes each.  100 µl of the substrate 
solution was added to each well and the plate was incubated at room temperature for 
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30 minutes before adding 100 µl of stop solution into each well.  The Multiscan 
Microplate Spectrophotometer (Thermo-Fisher Scientific, Rockford, IL) and ScanIt 2.4.4 
Software (Thermo-Fisher Scientific, Rockford, IL) were utilized to measure the optical 
density of each standard and sample at 450 nm.  A standard curve of optical density was 
generated using Microsoft Excel 2007.  A line of best fit was generated and the 
corresponding equation was used to calculate the amount of endothelin-1 protein in 
each urine sample based upon its optical density. 
Western Blot Analysis 
 
Solubilization of the Kidneys 
 
Six kidneys randomly chosen from six rats in each group, female SHR exercised 
(F-SHR-E), female SHR sedentary (F-SHR-S), female WKY exercised (F-WKY-E), female 
WKY sedentary (F-WKY-S), male SHR exercised (M-SHR-E), male SHR sedentary (M-SHR-
S), male WKY exercised (M-WKY-E), and male WKY sedentary (M-WKY-S) were 
pulverized between two pieces of one inch thick sheet metal by direct force using a 
hammer.  The pulverized tissue was resuspended in 1X SDS Sample Buffer [(50mM 
Tris/HCL (pH 6.8), 2% SDS (w/v), 0.1% (w/v) bromophenol blue, 10% glycerol (v/v), 
100mM Dithiothreitol] to a concentration of 0.1mg/ml. The tissue was solubilized using 
a dounce homogenizer and boiled for approximately five minutes before centrifugation 
at 2,000 x gravity for five minutes.  The solubilized kidney tissue was partitioned into 1.5 
microcentrifuge tubes and stored at -20o Celsius for future sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE). 
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SDS-PAGE and Transfer to Nitrocellulose Membrane 
 
The BioRad Model 422 electrophoresis chamber system (BioRad, Hercules, CA) 
was utilized in this experiment.  The glass gel casting plates were washed and rinsed 
with ethanol before being clipped into the casting plate holder.  Once the plates were in 
place, approximately ten ml of the lower resolving gel [(0.375M Tris/HCL (pH 8.8), 0.1% 
SDS (w/v), 9.9% acrylamide (w/v), 0.05% TEMED, 0.08% ammonium persulfate (w/v) (pH 
8.8))] was poured into each cast.  While waiting for the lower gel to solidify, the upper 
stacking gel, [(0.125M Tris/HCL (pH 7.0), 0.1% SDS (w/v), 4.8% acrylamide (w/v), 0.1% 
TEMED, 0.1% ammonium persulfate (w/v) (pH 7.0))], was mixed.  After the lower 
resolving gel had solidified, the casting plates were filled with approximately 5 ml of the 
upper stacking gel and 1.5 mm well combs were submerged into the gel.  Once the 
upper stacking gel had solidified, the combs were removed and the wells were washed 
with 1x SDS running buffer [(0.25M Tris/HCL, 1.92M Glycine, 1% SDS)] before the 
protein standard (Sigma High Molecular Weight Marker, Sigma-Aldrich, St. Louis, MO) 
and samples were added to their respective wells.  The gels were then inserted into 
separate electrical chambers filled with 1x SDS running buffer and connected to an 
electrical source.  The gels were resolved at 80 volts until the protein bands migrated 
below the stacking gel and then increased to approximately 120 volts for the next 90 
minutes.  The gels were removed from their chamber, the upper stacking gel taken off, 
and the lower resolving gel immersed in Coomassie Brilliant Blue protein stain [(0.25% 
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Coomassie brilliant blue R-250 (w/v), 45% methanol (v/v), 10% glacial acetic acid (v/v)] 
for 24 hours.  The Coomassie dye was removed and replaced with Coomassie destaining 
solution [(5% methanol (v/v), 7.5% glacial acetic acid (v/v)] until enough dye had been 
removed to visualize the bands of protein in the gel.  Each gel was scanned and analyzed 
using ImageJ software (National Institute of Health).  Based upon the results, the protein 
load was adjusted and SDS-PAGE was repeated to ensure an equal amount of protein in 
each kidney sample. 
After the optimal protein load was determined, proteins were resolved by SDS-
PAGE as previously described and transferred to nitrocellulose membrane (Whatman, 
Piscataway, NJ).  The BioRad Mini-Trans Blot electrophoretic transfer cell system 
(BioRad, Hercules, CA) was used to transfer the proteins.  Immediately after 
electrophoresis, the gel was removed from the electrical chamber and layered between 
two sheets of filter paper and one nitrocellulose membrane.  The gel was then squeezed 
inside in the cassette holder and placed inside the electrical chamber, which was filled 
with transfer buffer [(25mM Tris/HCL, 191.8 mM Glycine, 20% methanol (v/v))], before 
being connected to an electrical source.  The gels were transferred at 30 volts for four 
hours.  After transfer was complete, the membrane was removed and stored at -20o 
Celsius.  
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Western Blotting 
 
The nitrocellulose membrane was submerged in Ponceau staining solution [(5% 
Ponceau S (w/v), 0.05mM Trichloroacetic acid)] for approximately two minutes before 
being immersed in 1% glacial acetic acid solution two times for 15 seconds or until 
enough dye had been removed to visualize the bands of protein on the nitrocellulose.  
The protein standard was removed from the membrane using a razor blade and stored.  
Nonspecific binding sites were blocked by submerging the membrane in 10 milliliters of 
a commercially available Superblock solution (Thermo-Fisher Scientific, Rockford, IL) for 
15 minutes at room temperature.  The Superblock was removed and replaced with 5-10 
ml of a block solution that consisted of 50 ml 1x TweenTris-buffered saline (TTBS) 
[(136.89mM NaCl, 24.76mM Tris/HCL, 2.68mM KCL, 0.823mM Triton X-100)], 5% bovine 
serum albumin (Calbiochem-Novabiochem International, La Jolla, CA) and 1% 
inactivated fetal calf serum (FCS) for 30 minutes at room temperature.  The block was 
removed after 30 minutes and replaced with approximately two milliliters of the 
appropriate primary antibody diluted in block solution.  The primary antibodies used 
were: 1:250 dilution of ET-1 goat polyclonal IgG antibody (Santa Cruz Biotechnology, 
Santa Cruz, CA), 1:300 dilution of ET-A receptor mouse monoclonal IgG1 antibody (Santa 
Cruz Biotechnology, Santa Cruz, CA), and 1:100 dilution of ET-B rabbit polyclonal IgG 
antibody (Santa Cruz Biotechnology, Santa Cruz, CA).  The nitrocellulose membrane was 
incubated overnight at 4o Celsius.  The membrane was removed from the solution and 
washed with 1x TTBS, three times for ten minutes each.  This was followed by 
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incubation with 3-5 ml of an appropriate enzyme conjugated secondary antibody diluted 
in block and applied to the nitrocellulose membrane for 2-4 hours at room temperature.  
The secondary antibodies used in this experiment were: 1:3500 dilution of alkaline 
phosphatase conjugated anti-goat IgG antibody produced in rabbit (Sigma-Aldrich, St. 
Louis, MO), 1:5000 dilution of alkaline phosphatase conjugated anti-mouse IgG antibody 
produced in goat (Sigma-Aldrich, St. Louis, MO), and 1:3000 dilution of alkaline 
phosphatase conjugated anti-rabbit IgG antibody produced in goat (Sigma-Aldrich, St. 
Louis, MO). The membrane was removed from the solution and washed with 1x TTBS 
three times for ten minutes each. The membrane was briefly washed in substrate buffer 
[(0.1mM Tris/HCL, 25mM diethanolamine, 0.1M NaCl, 2mM MgCl2, 1 µM ZnCl2 (pH 
9.55))].  Antibodies bound to the nitrocellulose membrane were detected via the 
addition of substrate buffer with 0.4 µM of Nitro Blue Tetrazolium Chloride (NBT) (Tokyo 
Chemical Industry Corporation, Tokyo, Japan), 1.57 µM of 5-Bromo-4-Chloro-3-Indoyl 
Phosphate Disodium Salt (BCIP) (USB Corporation, Cleveland, OH), and 4.37 µM of 
Phenazine Methosulfate (PMS) for three to five minutes at room temperature.  The 
developer was removed after purple bands developed on the nitrocellulose membrane.  
The membrane was washed in deionized water and stored at 4o Celsius.   
Image Analysis 
The image of the gel or nitrocellulose membrane was analyzed using Image J 
software. The protein band or lane of interest was selected and a profile was generated 
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to determine the relative amount of protein in each lane and the relative reactivity of 
the immunoblot in the kidney samples from each experimental subset of rats. 
Immunohistochemistry 
 
Cryosectioning 
 
5-7 µm sections of frozen kidneys from each experimental group were prepared 
using a Leica CM 1850 UV cryostat (Leica Microsystems, Buffalo Grove, IL).  Each section 
was transferred to a VistaVision HistoBond microscope slide (VWR International, 
Radnor, PA) and stored at -20o Celsius. 
Immunostaining 
Prior to staining, each tissue section was outlined using liquid blocking pap pen 
(Daido Sangyo Corporation, Tokyo, Japan) and rinsed for approximately two minutes in 
PBS.  The tissue was fixed with 0.1% paraformaldehyde in PBS at room temperature for 
15 minutes.  After removing the fixative, each slide was overlaid with 10 mM 
ethanolamine in PBS for 10 minutes to quench the excess paraformaldehyde followed 
by a methanol shock at -20o Celsius for 5 minutes to permeabilize the kidney tissue.  The 
tissue was rehydrated in PBS for approximately 5 minutes before a blocking solution  
(1x PBS, 5% BSA, 1% inactivated FCS) was added to each section.  After approximately 
one hour, the blocking solution was removed and replaced with the appropriate 
antibody diluted in the blocking solution.  A 1:100 dilution of a monoclonal anti-actin 
antibody conjugated with Cy3 (Sigma-Aldrich, St. Louis, MO) was used as a positive 
control.  The primary antibodies used were: 1:50 dilution of ET-1 goat polyclonal IgG 
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antibody (Santa Cruz Biotechnology, Santa Cruz, CA), 1:100 dilution of ET-A receptor 
mouse monoclonal IgG1 antibody (Santa Cruz Biotechnology, Santa Cruz, CA), and  1:50 
dilution of ET-B rabbit polyclonal IgG antibody (Santa Cruz Biotechnology, Santa Cruz, 
CA).  Following overnight incubation at 4o Celsius, each slide was washed 3 times, for 15 
minutes in PBS.  Kidney tissue that was previously exposed to ET-1 primary antibody was 
incubated with a 1:100 dilution of Alexa Fluor 488 rabbit anti-goat IgG antibody 
(Invitrogen Molecular Probes, Carlsbad, CA).  Kidney tissue that was previously treated 
with ET-A primary antibody was incubated with a 1:1500 dilution of Alexa Fluor 555 goat 
anti-mouse IgG antibody (Invitrogen Technologies, Carlsbad, CA).  Kidney tissue that was 
previously exposed to ET-B primary antibody was incubated with a 1:25 dilution of goat 
anti-rabbit IgG-PerCP-Cy5.5 antibody (Santa Cruz Biotechnology, Santa Cruz, CA).  After 
2-4 hours of incubation at room temperature, each slide was washed 3 times, 15 
minutes each time, in PBS.  Number 1 coverslips (VWR International, Radnor, PA) were 
applied to each slide using ProLong Gold antifade reagent with DAPI media (Invitrogen 
Technologies, Carlsbad, CA) and sealed using a commercially available clear nail polish.  
The slides were stored at 4o Celsius.  
Immunofluorescence and Image Capturing Software 
The mercury lamp was powered on before turning on the Olympus BX40 
trinocular fluorescence microscope (Olympus, Center Valley, PA) and the Hamamatsu 
C8484 digital camera (Hamamatsu Photonics, Hamamatusu City, Japan).  The prepared 
slide was placed on the stage and secured with the stage clips.  Once the specimen was 
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centered and focused, the bright field light was turned off and replaced with the 
fluorescent light and the appropriate wavelength excitation filter.  The DAPI stain on 
each slide was visualized using the WU excitation filter (excitation: 359 nm; emission: 
461 nm).  Slides that were stained with ET-1 were viewed using the FITC excitation filter 
(excitation: 490 nm; emission: 525 nm) and slides that were stained with either ET-A or 
ET-B were viewed using the TRITC excitation filter (excitation: 557 nm; emission: 576 
nm).  If more than one antibody was being viewed at once, the multi-excitation filter 
was utilized.  Once a suitable image was found, the view of the microscope was 
switched to the camera setting so it could be captured using the digital camera 
attachment. Digitized images were acquired using Simple PCI imaging software 
(Hamamatsu Photonics, Hamamatsu City, Japan). 
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RESULTS 
To evaluate the effect of exercise on endothelin and endothelin receptors, male 
and female hypertensive and normotensive rats were either restricted from exercise 
(sedentary groups) or provided an exercise wheel (exercised groups) for eleven weeks. 
Subsequently, the total exercise distance and kidney and body mass of each rat was 
determined, the relative amount of ET-1 and ET-A and ET-B receptors in the kidney 
lysate was evaluated, and level of ET-1 excreted in the urine was measured.  
Immunofluorescence studies also characterized the localization of ET-1 and ET-A and  
ET-B receptors within the renal tissue and cells. 
Exercise Distance  
A total of 4 groups were exercised including male hypertensive (M-SHR-E), 
female hypertensive (F-SHR-E), male normotensive (M-WKY-E) and female 
normotensive (F-WKY-E). The total distance ran over the duration of the experiment 
was compared for each group (Table 1; Figure 10). Overall, the level of exercise activity 
was diminished at the onset and at the end of the study (week 1 and week 11, 
respectively), with the highest level of activity during weeks 2 through 10.  Female SHR 
rats ran a significantly greater distance overall with increased levels during weeks 2, 3, 4, 
and 6 relative to male SHR rats (Figure 11).  Although female WKY rats exercised more 
than male WKY rats, the difference in running distances was not statistically significant 
(Figure 12).  In addition, WKY rats exercised more overall than SHR rats, regardless of 
sex. 
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Kidney and Body Mass  
As an initial means of characterization of the differences between exercised and 
sedentary hypertensive and normotensive rats, the total kidney, body, and kidney (mg): 
body (g) mass was determined after eleven weeks.  The mean kidney and body mass of 
female rats was significantly less than the mean kidney and body mass of male rats of 
the same strain and activity level (Table 2; Figure 13; Table 3; Figure 14).  The mean 
kidney mass was significantly greater in exercised female WKY and female SHR rats 
relative to sedentary female WKY and female SHR rats.  In addition, exercised female 
WKY and male WKY rats had a larger body mass than their sedentary counterpart.  In 
general, WKY rats had an increased mean kidney and body mass relative to SHR rats. 
The mean kidney: mean body mass ratio was slightly, but not significantly 
greater in exercised female SHR, female WKY, and male SHR rats relative to their 
sedentary counterparts (Table 4; Figure 15).  Exercised male WKY rats had a significantly 
increased kidney: body ratio relative to sedentary male WKY rats. There was no 
difference in the ratio between female and male rats of the same strain and activity 
level.  
The amount of total work, as determined by multiplying the mean body weight 
by the mean weekly running distance of each group of exercised rats, was greater in 
male and female WKY rats relative to male and female SHR rats (Table 5; Figure 16). 
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Levels of Endothelin in Urine 
 To determine if increased exercise activity led to an increase in endothelin 
excretion, the amount of ET-1 in urine pooled from each group of rats was analyzed 
using an ET-1 ELISA.  The absorbance value of ET-1 standards were used to construct a 
linear curve (slope intercept form y = 0.0099x + 0.0064, coefficient of determination = 
0.9964) (Table 6; Figure 17).  The level of ET-1 in each urine sample was extrapolated 
from the standard curve.   
The ELISA results demonstrated: 1) the amount of ET-1 was greater in the pooled 
urine of female SHR sedentary, female WKY exercised, and female WKY sedentary rats, 
but not female SHR exercised rats, relative to males of the same strain and activity level; 
2) male and female WKY rats excreted more ET-1 than SHR rats; 3) the effect of exercise 
on ET-1 levels was inconsistent between WKY and SHR rats.  The urine of exercised WKY 
rats contained more ET-1 than WKY sedentary rats and on the contrary, the urine of 
exercised SHR rats contained less ET-1 than SHR sedentary rats (Table 7; Figure 18). 
Endothelin and Endothelin Receptor Levels in Solubilized Kidney Tissue 
To evaluate the effect of exercise on ET-1 and ET-A and ET-B receptors, 
homogenized renal lysates from each group were resolved by SDS-PAGE, probed using 
Western blot analysis, and quantitated using Image J software (Figure 19; Figure 20; 
Figure 21; Figure 22).  In the case of ET-A, 1) the amount of receptors was greater in the 
kidney homogenate of SHR rats relative to WKY rats; 2) receptor levels were greater in 
the kidney tissue of males relative to females of the same strain and activity level, with 
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male SHR exercised rats being the only exception; 3) Exercise had various effects on the 
level of ET-A in the kidney tissue of each group of rats.  Male SHR sedentary rats had an 
increased level of ET-A relative to male SHR exercised rats;  conversely, female SHR 
sedentary rats had a decreased level of ET-A relative to female SHR exercised rats; 4) the 
effect of exercise had an opposite impact on WKY rats, with a decrease in ET-A levels in 
male WKY sedentary rats relative to male WKY exercised rats and an increase in ET-A 
levels in female WKY sedentary rats relative to female WKY exercised rats (Table 8;Table 
9; Figure 23).  In the case of ET-B, receptors were detectable in the kidney homogenate 
of female SHR exercised rats but were not observed in any of the other group of rats 
(Figure 24).  ET-1 levels were undetectable in all kidney homogenates.  
Endothelin and Endothelin Receptor Localization within Kidney Tissue 
The effect of exercise on the localization patterns of ET-1 and ET-A and ET-B 
receptors within the renal tissue and cells of each group of rats was determined using 
immunofluorescence microscopy on cryosections.  Renal tissue from each group of rats 
was probed with an anti-actin antibody as a positive control.  Broad actin staining 
localized around the proximal and distal tubules, perimeter of cells, and small blood 
vessels was found throughout each sample (Figure 25).   
A common pattern of ET-A receptor staining was seen throughout each 
experimental group  of rats (Figure 26; Figure 27; Figure 28; Figure 29; Figure 30; Figure 
31; Figure 32; Figure 33; Figure 34; Figure 35; Figure 36; Figure 37; Figure 38; Figure 39; 
Figure 40; Figure 41).  Broad ET-A receptor staining was consistently localized around 
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the perimeter of both proximal and distal convoluted tubules, with the most intense 
staining coinciding with the extracellular membrane.  Intracellular cytoplasmic staining 
was noted within the structures of the nephron.  ET-A receptors were also evenly 
distributed throughout epithelial wall of the Bowman’s capsule and the glomerular 
matrix of the renal corpuscle.  Kidney tissue extracted from sedentary male SHR rats had 
the most intense ET-A receptor staining.  In comparison with sections of lower intensity, 
the staining of the face of the tubular extracellular membrane was greatly increased in 
sedentary male SHR rats. 
Similar to ET-A receptors, ET-B receptor staining was very broad and evenly 
distributed throughout the majority of the components of the nephron (Figure 42; 
Figure 43; Figure 44; Figure 45).  However, ET-B receptor staining was much less intense 
than renal sections stained with ET-A receptor primary antibody.  Unlike ET-A receptor 
staining, intense ET-B receptor staining was only observed in kidney tissue extracted 
from exercised female SHR rats.   
4',6-diamidino-2-phenylindole (DAPI) is a fluorescent stain that binds strongly to 
nucleic acids.  There was a general overlap of DAPI and ET-A receptor and ET-B receptor 
staining; however, DAPI was more centrally localized within the cells that surround the 
perimeter of several renal structures, including blood vessels, proximal convoluted 
tubules, and distal convoluted tubules.  DAPI staining was also well punctated 
throughout the renal corpuscle and glomerulus of the nephron.   
 53 
 
Renal sections stained with the appropriate secondary antibody independent of 
the ET-A receptor and ET-B receptor primary antibodies served as a negative control.  
Nonspecific interstitial renal secondary antibody staining varied among the groups of 
experimental rats; however, it was generally very minimal. 
Unlike ET-A receptor and ET-B receptor staining, kidney tissue stained with ET-1 
primary antibody was indiscernible from kidney tissue stained only with secondary 
antibody (Figure 46). 
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Table 1.  Mean Weekly Exercise Distance.  The mean exercise distance (km) of each 
experimental group of rats.  Values are reported as mean ± standard error. 
* p ≤ 0.05 when compared to weekly exercise distance of males of the same strain. 
† p ≤ 0.05 when compared to overall exercise distance of males of the same strain. 
 
 
 
 
 
 
 
 
 
 
Week  
1 
Week 
 2 
Week 
 3 
Week 
 4 
Week 
 5 
Week 
 6 
Week 
 7 
Week 
 8 
Week 
9 
Week 
 10 
Week 
 11 
Total 
Mean 
Weekly 
Distance 
Male SHR 
 
22.38 23.6 23.15 42.59 38.58 33.93 46.94 38.38 49.37 48.49 27.88 395.28 35.93 
Male WKY 
 
12.13 27.51 47.93 51.5 50.54 56.76 54.54 58.68 45.21 47.07 25.32 477.19 43.38 
Female SHR† 
 
39.79 60.99* 62.27* 79.56* 69.49 65.41* 63.99 64.91 56.36 43.51 35.86 576.73 52.43 
Female WKY 
 
20.68 48.98 69.34 62.81 81.2 63.34 71.63 68.55 64.46 69.03 43.74 663.76 60.34 
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Figure 10.  Mean Weekly Exercise Distance.  The mean weekly exercise distance (km) of each 
experimental group of rats.  Values are reported as mean ± standard error. 
* p < 0.05 when compared to weekly distance of males of the same strain. 
 † p < 0.05 when compared to overall distance of males of the same strain. 
 
 
 
 
 
 
0
10
20
30
40
50
60
70
80
90
0 1 2 3 4 5 6 7 8 9 10 11
D
is
ta
n
ce
 (
km
) 
Week 
Male SHR
Male WKY
Female SHR
Female WKY
† 
 
 56 
 
 
 
Figure 11.  Mean Weekly SHR Exercise Distance.  The mean weekly exercise distance of SHR 
male and female rats.  Values are reported as mean ± standard error. 
*p < 0.05 when compared to weekly exercise distance of males. 
† p <0.05 when compared to overall exercise distance of males. 
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Figure 12.  Mean Weekly WKY Exercise Distance.  The mean weekly exercise distance of WKY 
male and female rats.  Values are reported as mean ± standard error.  
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Table 2.  Mean Kidney Mass.  The mean kidney mass (g) of each experimental group of rats.  
Values are reported as mean ± standard error. 
 
 
Figure 13.  Mean Kidney Mass.  The mean kidney mass (g) of each experimental group of rats.  
Values are reported as mean ± standard error. 
* p < 0.05 when compared to mean kidney mass of sedentary rats of the same sex and strain. 
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Rat Subset Mean Kidney Mass (g) ± SEM 
F-SHR-E 1.04 0.014 
F-SHR-S  0.96 0.018 
F-WKY-E 1.69 0.049 
F-WKY-S 1.42 0.053 
M-SHR-E 1.65 0.036 
M-SHR-S 1.61 0.035 
M-WKY-E 2.26 0.083 
M-WKY-S 2.29 0.061 
*  
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Table 3.  Mean Body Mass.  The mean body mass (g) of each experimental group of rats prior to 
surgical removal of their kidneys.  Values are reported as mean ± standard error. 
 
 
 
Figure 14.  Mean Body Mass.  The mean body mass (g) of each experimental group of rats prior 
to surgical removal of their kidneys.  Values are reported as mean ± standard error. 
* p < 0.05 when compared to mean body mass of sedentary rats of the same sex and strain. 
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F-SHR-E 220.6 5.36 
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Rat Subset Mean Kidney Mass (g): Mean Body Mass (mg) ± SEM 
F-SHR-E 4.79 0.15 
F-SHR-S 4.51 0.11 
F-WKY-E 5.40 0.23 
F-WKY-S 5.10 0.17 
M-SHR-E 4.82 0.13 
M-SHR-S 4.64 0.09 
M-WKY-E 5.16 0.15 
M-WKY-S 4.76 0.09 
Table 4.  Mean Kidney to Body Mass Ratio.  The ratio of mean kidney mass (g) to mean body 
mass (mg) of each experimental group of rats.  Values are reported as mean ± standard error. 
 
 
 
Figure 15.  Mean Kidney to Body Mass Ratio. The ratio of mean kidney mass (g) to mean body 
mass (mg) of each experimental group of rats.  Values are reported as mean ± standard error. 
* p < 0.05 when compared to the ratio of mean kidney mass to mean body mass of sedentary 
rats of the same sex and strain. 
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Rat Subset Total Work 
F-SHR-E 11566.06 
F-WKY-E 18946.76 
M-SHR-E 12331.18 
M-WKY-E 19108.89 
Table 5.  Total Work.  The total work of each exercised group of rats determined by multiplying 
mean body mass (g) by mean weekly running distance. 
 
 
                 
Figure 16. Total Work.  The total work of each exercised group of rats determined by 
multiplying mean body mass (g) by mean weekly running distance. 
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Standard ET-1 Concentration (pg/mL) Absorbance 
1 0 0.0012 
2 0.78 0.0007 
3 1.56 0.0096 
4 3.13 0.0323 
5 6.25 0.0701 
6 12.5 0.161 
7 25 0.2817 
8 50 0.469 
9 100 0.9983 
Table 6.  Absorbance of ELISA Standards.  The absorbance of each Endothelin-1 standard 
solution derived from ELISA analysis. 
 
 
Figure 17.  ELISA Standard Curve.  The standard curve of Endothelin-1 concentration (pg/ml) vs. 
absorbance derived from Table 5.  Y=0.0099x + 0.0064; R2=0.9964. 
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Table 7.  Urinary Endothelin-1 Levels.  The concentration (pg/ml) of endothelin-1 in pooled 
urine from each experimental subset of rats as determined by ELISA analysis. 
 
 
 
Figure 18.  Urinary Endothelin-1 Levels.  The amount of endothelin-1 (pg/ml) in pooled urine 
from each experimental subset of rats as determined by ELISA analysis. 
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Figure 19.  SDS-PAGE and Western Blot Composite.  SDS-PAGE and Western Blot 
analysis of total protein and Endothelin expression in the kidney tissue extracted from 
each experimental group of rats.  A.)  Coomassie gel depicting the total kidney protein 
load. B.)  Western Blot probed with Endothelin-A antibody.  C.)  Western Blot probed 
with Endothelin-B antibody.  D.)  Western Blot probed with Endothelin-1 antibody. 
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Figure 20.  Total Protein Densitometry.  Densitometry of total protein load in each lane of 
Coomassie gel as determined by Image J Software. 
 
 
 
Figure 21.  Endothelin-A Densitometry.  Densitometry of Endothelin-A in Western Blot analysis 
as determined by Image J Software. 
 
 66 
 
 
 
 
Figure 22.  Endothelin-B Densitometry.  Densitometry of Endothelin-B in Western Blot analysis 
as determined by Image J Software.  
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Coomassie ET-A ET-B 
F-SHR-E 26622 20644 22270 
F-SHR-S 27192 17934 1452 
F-WKY-E 28671 13144 2210 
F-WKY-S 25220 11969 2636 
M-SHR-E 28404 19407 2796 
M-SHR-S 25932 20830 1894 
M-WKY-E 27864 17980 1409 
M-WKY-S 26370 13145 3301 
Table 8.  Total Protein and Endothelin Receptor Levels.  The total protein load and the levels 
of Endothelin-A and Endothelin-B in the kidney homogenate of each experimental group of 
rats as determined by Image J analysis of Coomassie gel and Western Blots. 
 
 
 
ET-A ET-B 
F-SHR-E 0.7754 0.8365 
F-SHR-S 0.6595 0.0534 
F-WKY-E 0.4584 0.0771 
F-WKY-S 0.4746 0.1045 
M-SHR-E 0.6832 0.0984 
M-SHR-S 0.8033 0.0730 
M-WKY-E 0.6453 0.0506 
M-WKY-S 0.4985 0.1252 
Table 9.  Endothelin Receptor Levels Relative to Total Protein.  The levels of Endothelin-A and 
Endothelin-B in the kidney homogenate of each experimental group of rats relative to the 
total protein load in the Coomassie gel. 
 
 
 
 68 
 
 
Figure 23.  Endothelin-A Receptor Levels.  The amount of endothelin-A receptors in the kidney 
homogenate of each experimental group of rats relative to total protein levels in the Coomassie 
gel as determined by Image J analysis of Western Blots. 
 
 
Figure 24.  Endothelin-B Receptor Levels.  The amount of endothelin-B receptors in the kidney 
homogenate of each experimental group of rats relative to total protein levels in the Coomassie 
Gel as determined by Image J analysis of Western Blots. 
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Figure 25. Actin Immunofluorescent  Localization.  The general actin localization pattern seen in 
each experimental group of rats.  Each image in the figure was acquired with the 40x objective 
and a 10 second exposure time.  A.)  Sedentary female WKY rat.  B.)  Exercised female SHR rat.  
C.)  Exercised male WKY rat. 
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Figure 26.  Immunofluorescent Localization of ET-A Receptors in F-SHR-E (20x).  
Immunohistochemical analysis of ET-A receptors in an exercised female SHR rat.  Each image in 
the figure was acquired with the 20x objective and a 4 second exposure time.  A.)  Kidney 
section probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-A antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
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Figure 27.  Immunofluorescent Localization of ET-A Receptors in F-SHR-E (40x).  
Immunohistochemical analysis of ET-A receptors in an exercised female SHR rat.  Each image in 
the figure was acquired with the 40x objective and a 5 second exposure time.  A.)  Kidney 
section probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-A antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
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Figure 28.  Immunofluorescent Localization of ET-A Receptors in F-SHR-S (20x).  
Immunohistochemical analysis of ET-A receptors in a sedentary female SHR rat.  Each image in 
the figure was acquired with the 20x objective and a 4 second exposure time.  A.)  Kidney 
section probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-A antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
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Figure 29.  Immunofluorescent Localization of ET-A Receptors in F-SHR-S (40x).  
Immunohistochemical analysis of ET-A receptors in a sedentary female SHR rat.  Each image in 
the figure was acquired with the 40x objective and a 5 second exposure time.  A.)  Kidney 
section probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-A antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
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Figure 30.  Immunofluorescent Localization of ET-A Receptors in F-WKY-E (20x).  
Immunohistochemical analysis of ET-A receptors in an exercised female WKY rat.  Each image in 
the figure was acquired with the 20x objective and a 7 second exposure time.  A.)  Kidney 
section probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-A antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
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Figure 31.  Immunofluorescent Localization of ET-A Receptors in F-WKY-E (40x).  
Immunohistochemical analysis of ET-A receptors in an exercised female WKY rat.  Each image in 
the figure was acquired with the 40x objective and a 4 second exposure time.  A.)  Kidney 
section probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-A antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
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Figure 32.  Immunofluorescent Localization of ET-A Receptors in F-WKY-S (20x).  
Immunohistochemical analysis of ET-A receptors in a sedentary female WKY rat.  Each image in 
the figure was acquired with the 20x objective and a 7 second exposure time.  A.)  Kidney 
section probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-A antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
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Figure 33.  Immunofluorescent Localization of ET-A Receptors in F-WKY-S (40x).  
Immunohistochemical analysis of ET-A receptors in a sedentary female WKY rat.  Each image in 
the figure was acquired with the 40x objective and a 4 second exposure time.  A.)  Kidney 
section probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-A antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
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Figure 34.  Immunofluorescent Localization of ET-A Receptors in M-SHR-E (20x).  
Immunohistochemical analysis of ET-A receptors in an exercised male SHR rat.  Each image in 
the figure was acquired with the 20x objective and a 5 second exposure time.  A.)  Kidney 
section probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-A antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
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Figure 35.  Immunofluorescent Localization of ET-A Receptors in M-SHR-E (40x).  
Immunohistochemical analysis of ET-A receptors in an exercised male SHR rat.  Each image in 
the figure was acquired with the 40x objective and a 5 second exposure time.  A.)  Kidney 
section probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-A antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
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Figure 36.  Immunofluorescent Localization of ET-A Receptors in M-SHR-S (20x).  
Immunohistochemical analysis of ET-A receptors in a sedentary male SHR rat.  Each image in the 
figure was acquired with the 20x objective and a 6 second exposure time.  A.)  Kidney section 
probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with Endothelin-A 
antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section probed with 
secondary antibody. 
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Figure 37.  Immunofluorescent Localization of ET-A Receptors in M-SHR-S (40x).  
Immunohistochemical analysis of ET-A receptors in a sedentary male SHR rat.  Each image in the 
figure was acquired with the 40x objective and a 5 second exposure time.  A.)  Kidney section 
probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with Endothelin-A 
antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section probed with 
secondary antibody. 
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Figure 38.  Immunofluorescent Localization of ET-A Receptors in M-WKY-E (20x).  
Immunohistochemical analysis of ET-A receptors in an exercised male WKY rat.  Each image in 
the figure was acquired with the 20x objective and a 5 second exposure time.  A.)  Kidney 
section probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-A antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
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Figure 39.  Immunofluorescent Localization of ET-A Receptors in M-WKY-E (40x).  
Immunohistochemical analysis of ET-A receptors in an exercised male WKY rat.  Each image in 
the figure was acquired with the 40x objective and a 3.5 second exposure time.  A.)  Kidney 
section probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-A antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
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Figure 40.  Immunofluorescent Localization of ET-A Receptors in M-WKY-S (20x).  
Immunohistochemical analysis of ET-A receptors in a sedentary male WKY rat.  Each image in 
the figure was acquired with the 20x objective and a 8 second exposure time.  A.)  Kidney 
section probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-A antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
 85 
 
 
Figure 41.  Immunofluorescent Localization of ET-A Receptors in M-WKY-S (40x).  
Immunohistochemical analysis of ET-A receptors in a sedentary male WKY rat.  Each image in 
the figure was acquired with the 40x objective and a 7 second exposure time.  A.)  Kidney 
section probed with Endothelin-A and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-A antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
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Figure 42.  Immunofluorescent Localization of ET-B Receptors in F-SHR-E (20x).  
Immunohistochemical analysis of ET-B receptors in an exercised female SHR rat.  Each image in 
the figure was acquired with the 20x objective and a 10 second exposure time.  A.)  Kidney 
section probed with Endothelin-B and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-B antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
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Figure 43.  Immunofluorescent Localization of ET-B Receptors (20x).  The general ET-B receptor 
localization pattern and intensity seen in every experimental group of rats other than exercised 
female SHR rats.  Each image in the figure was acquired with the 20x objective and a 10 second 
exposure time.  A.)  Kidney section probed with Endothelin-B and DAPI antibodies.  B.)  Kidney 
section probed with Endothelin-B antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  
Kidney section probed with secondary antibody. 
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Figure 44.  Immunofluorescent Localization of ET-B Receptors in F-SHR-E (40x).  
Immunohistochemical analysis of ET-B receptors in an exercised female SHR rat.  Each image in 
the figure was acquired with the 40x objective and a 10 second exposure time.  A.)  Kidney 
section probed with Endothelin-B and DAPI antibodies.  B.)  Kidney section probed with 
Endothelin-B antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  Kidney section 
probed with secondary antibody. 
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Figure 45.  Immunofluorescent Localization of ET-B Receptors (40x).  The general ET-B receptor 
localization pattern and intensity seen in every experimental group of rats other than exercised 
female SHR rats.  Each image in the figure was acquired with the 40x objective and a 10 second 
exposure time.  A.)  Kidney section probed with Endothelin-B and DAPI antibodies.  B.)  Kidney 
section probed with Endothelin-B antibody.  C.)  Kidney section probed with DAPI antibody.  D.)  
Kidney section probed with secondary antibody. 
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Figure 46.  Immunofluorescent Localization of ET-1.  The general ET-1 localization pattern and 
intensity seen in each experimental group of rats.  Each image in the figure was acquired with 
the 20x objective and a 6 second exposure time.  A.)  Kidney section probed with ET-1 primary 
antibody and secondary antibody.  B.)  Kidney section probed with secondary antibody. 
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DISCUSSION 
Previous studies in the laboratory of Dr. Penny Knoblich have shown that 
exercise increases the amount of sodium excreted in the urine of female WKY and SHR 
rats.  The purpose of this study is to determine if the endothelin system, composed of 
ET-1 and ET-A and ET-B receptors, contributes to this effect.  The effect of exercise on 
the renal endothelin system of male and female WKY and SHR rats was evaluated by 
SDS-PAGE and Western Blot analysis, enzyme-linked immunosorbent assay, and 
immunofluorescence microscopy.  The body and kidney mass of each rat was also 
recorded to analyze the effect exercise has on kidney and overall bodily growth. 
Exercise Behavior 
 To determine the effect of exercise and sex on the endothelin system of WKY 
and SHR rats, male and female rats of each strain voluntarily exercised on a wire wheel 
for eleven weeks.  Consistent with previous studies, female rats ran a greater distance 
overall compared to male rats (77; 78).  Female SHR rats exercised significantly more 
throughout the entire experiment and during weeks 2, 3, 4, and 6 relative to male SHR 
rats.  Female WKY rats also exercised more than their male counterpart; however the 
difference was not statistically significant.  According to Wang and associates, female 
rats have a higher general level of spontaneous activity due to a stimulus arising from 
the internal secretion of the ovaries (79).  Unlike caged male rats, females exercise in 
excess every four days and this periodic fluctuation in activity has been correlated with 
their ovulation cycle (79).  Female rats with their ovaries removed tend to be less active 
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than normal females (79).  Similarly, the transplantation of ovaries to castrated male 
rats results in an activity curve similar to that observed in females (79). 
 In addition to an observed correlation between sex and exercise behavior, it was 
noted that rats of the WKY strain ran a greater total distance relative to SHR rats.  The 
amount of total work, as determined by multiplying the mean body weight by the mean 
weekly running distance of each group of exercised rats, was greater in male and female 
WKY rats relative to male and female SHR rats.  This finding is consistent with previous 
studies (73; 76).  According to Kingwell, WKY rats run a greater distance relative to SHR 
rats due to an exercise induced increase in aortic elasticity or compliance, which allows 
the aorta to more easily accommodate a rise in arterial blood volume associated with 
exercise (73).  In contrast with WKY rats, Kingwell suggests that SHR rats run a lesser 
distance due an increased blood pressure and lack of ability to alter their aortic 
compliance (80). 
Kidney and Body Mass 
 It is well documented that male rats have an increased kidney and body mass 
relative to female rats (81) and that rats of the WKY strain have an increased kidney and 
body mass relative to rats of the SHR strain (67).  Our data are consistent with this 
trend. The mean kidney and body mass of female rats was significantly decreased 
relative to male rats and the mean kidney and body mass of SHR rats was significantly 
decreased relative to WKY rats. 
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 Limited information is available of the effect of exercise on the kidney and body 
mass of male and female SHR and WKY rats.  However, this study revealed that 
exercised female WKY and SHR rats had a significantly increased kidney mass and 
female WKY rats had a significantly increased body mass compared to sedentary female 
WKY and SHR rats.  This result is not consistent with prior studies in which exercised 
female rats have been reported to maintain a body weight similar to sedentary rats (82).  
One possible explanation for the anomaly is that exercise may promote alterations in 
the body composition of female rats, such as an increase in muscle mass and or a 
depression in body fat. 
 It was observed that exercised male WKY rats had a significantly decreased body 
mass and an elevated ratio of mean kidney mass to mean body mass relative to 
sedentary rats of the same sex and strain.  Exercise has been reported in a similar study 
to contribute to a decrease in the body mass of male rats compared to sedentary male 
rats due to an increase in energy expenditure (82).  The reduced body weight of 
exercised males caused the increase in mean kidney mass to mean body mass observed 
in exercised male WKY rats.   
Levels of Renal Endothelin-A Receptor 
 In Western blot analysis, ET-A receptor levels were elevated in SHR rats relative 
to WKY rats, suggesting that protein expression was upregulated in the kidneys of SHR 
rats.  These results are consistent with previous studies in which an overexpression of 
ET-A receptor in the glomeruli and smooth muscle cells of intrarenal arteries of SHR rats 
 94 
 
compared to age-matched WKY rats was detected (55).  Hocher also determined that 
SHR rats injected with bosentan, an ET-A/ET-B antagonist, experience a decrease in 
blood pressure and increase in renal blood flow of the same magnitude as SHR rats 
injected with BQ-123, an ET-A antagonist (55).  These results suggest that vascular ET-A 
overexpression regulates renal blood flow and contributes to high blood pressure in SHR 
rats and may explain the upregulation of ET-A receptor levels in the renal tissue of SHR 
rats relative to WKY rats observed in this study. 
  The results of the experiment also suggest that high ET-A expression in SHR rats 
might be a compensatory mechanism for low levels of ET-1 excreted in the urine of SHR 
rats relative to WKY rats.  Receptors commonly increase their number or decrease their 
degradation with a reduction in circulating ligand (14). 
Exercise had a variable effect on renal ET-A receptor expression.  Western blot 
analysis of exercised female SHR and exercised male WKY rats revealed an increased 
level of ET-A receptors relative to their sedentary counterparts. Exercised female WKY 
and exercised male SHR rats had a decreased level of ET-A receptors relative to their 
sedentary counterparts.  The variable effect of exercise on ET-A receptor expression 
suggests that ET-A receptors are not responsible for inducing the natriuretic response of 
exercised female SHR and WKY rats previously described in the laboratory of Dr. Penny 
Knoblich (76).   
ET-A expression was determined by Western blot analysis to be increased in the 
kidney tissue of male rats relative to female rats of the same strain and activity level, 
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with male SHR exercised rats being the only exception.  Other studies have reported a 
similar ET-A receptor increase in males compared to females.  Human males have been 
reported to have an increased ratio of ET-A to ET-B receptors relative to age-matched 
women.  According to Ergul and colleagues, the saphenous veins from men contain a 
greater number of ET-A receptors than women and the ratio of ET-A to ET-B receptors is 
3:1 in men compared to 1:1 in women (83).  Ergul has also reported two-fold greater  
ET-1-induced contractions in males relative to females and believes that the 
overabundance of ET-A receptors in men is responsible for this contractile 
response (83).   
Because ET-A receptors are involved in the vasoconstrictive response to ET-1 and 
male experimental models of hypertension tend to have a more severe form of 
hypertension compared to females, the increase in renal ET-A expression was 
anticipated.  However, elevated male expression was not absolute as exercised female 
SHR rats exhibited slightly higher renal levels of ET-A receptors relative to exercised 
male SHR rats. Although this result was not predicted, it is consistent with a recent study 
that found that both ET-B and ET-A receptors contribute to ET-1 dependent natriuresis 
in female rats (84).  Intramedullary infusion of ET-1 produced greater diuretic and 
natriuretic responses in female rats relative to male rats primarily because of an ET-A 
receptor-dependent mechanism (84).  The natriuretic properties of ET-A receptors in 
female rats may explain the upregulation of renal ET-A observed in exercised female 
SHR rats compared to exercised male SHR rats in this study. 
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Levels of Renal Endothelin-B Receptor 
 Western blot analysis determined that renal tissue extracted from exercised 
female SHR rats exhibited a high level of ET-B receptor expression but ET-B receptors 
were undetectable in the renal tissue of all other experimental groups of rats.   
Studies over the past decade have clearly established that ET-B receptor 
activation by ET-1 is an important mechanism that serves to regulate and maintain the 
pressure-natriuresis relationship (28).  The selective deletion of ET-B receptor 
expression in collecting duct cells induces sodium retention and mean arterial pressure 
elevation in mice (85).  Studies from the laboratory of Dr. Penny Knoblich indicate that 
exercised female SHR and WKY rats excrete significantly more sodium in their urine than 
sedentary female SHR and WKY rats and exercised and sedentary male SHR and WKY 
rats in response to a rise in blood pressure (76).  These observations suggest that the 
increased level of natriuresis in the renal system of exercised female SHR and WKY rats 
corresponds with increased renal ET-B receptor expression.  Our results support this 
hypothesis in the case of exercised female SHR rats but not exercised female WKY rats.  
 However, a similar upregulation of ET-B receptor expression in SHR rats relative 
to WKY rats has been observed in other studies.  ET-B receptor mediated vasodilation is 
greater in SHR rats than normotensive control rats (47).  Previous research in the 
laboratory  of Dr. Penny Knoblich has reported higher sodium excretion levels in 
exercised female SHR rats in response to angiotensin II infusion relative to exercised 
female WKY rats (76).  According to Hocher and associates, an increased level of 
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vasodilation and natriuresis in SHR rats is caused by an overexpression of ET-B receptors 
in the glomeruli of SHR rats compared to age-matched WKY rats (55).  An increase in ET-
B receptor expression in response to high levels of blood pressure has also been 
reported by Lauth and associates (86).  According to Lauth, isolated segments of the 
rabbit jugular vein upregulate the expression of ET-B mRNA and functional ET-B protein 
in response to an increase in intraluminal perfusion pressure (86).  Given this 
information, it is possible to conclude that although an increase in renal ET-B receptor 
expression is believed to be responsible for higher levels of natriuresis in exercised 
female SHR rats, another unknown mechanism may be responsible for the previously 
observed increase in sodium excreted in the urine of exercised female WKY rats. 
 An increase in ET-B receptors in the renal tissue of exercised female SHR rats 
may be caused by the effect of exercise on ET-B receptor expression.  It is widely 
accepted that physical activity increases the level of vascular shear stress.  According to 
Taylor and associates, the amount of vascular wall shear stress is significantly increased 
in the human abdominal aorta following physical activity (87).  Studies have also 
reported a link between an increase in shear stress and an ET-B receptor upregulation.  
According to Morawietz and colleagues, human umbilical vein endothelial cells that are 
exposed to increasing degrees of long-term laminar shear stress upregulate ET-B 
receptor mRNA (49).  Similar studies have reported the overexpression of ET-B receptors 
in primary cultures of bovine aortic endothelial cells isolated from vessels previously 
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exposed to arterial shear stress in vivo (88) and canine arterial smooth muscle cells in 
response to chronic increases in blood flow (89). 
 An upregulation of renal ET-B receptors in exercised female SHR rats relative to 
male experimental groups of rats is believed to be caused by the effect of endothelial 
function on ET-B receptor expression. Males are known to have more endothelial 
dysfunction, be less responsive to NO-mediated arteriolar dilations, and experience a 
reduced natriuretic response to ET-1 relative to females (90).  Recent studies have also 
determined that the pressure-natriuresis relationship in SHR females is shifted toward 
lower blood pressures for a given level of sodium intake compared to SHR males (28).  
According to Kittikulsuth and associates, the lower level of natriuresis in angiotensin II 
hypertensive male rats is caused by their impaired renal ET-B receptor function and 
reduced number of ET-B receptor binding sites (91). 
Renal Localization of Endothelin-A and Endothelin-B Receptors 
 Staining with ET-A and ET-B receptor primary antibodies resulted in very broad 
immunofluorescence localization patterns that included staining of most of the nephron 
components, such as around the perimeter of proximal and distal convoluted tubules 
and within glomeruli of the renal corpuscles.  The localization of ET-A and ET-B receptors 
is consistent with a previous study conducted to determine the distribution of 
endothelin receptors within the rat kidney (57).  According to Wendel and associates, 
both ET-A and ET-B receptor immunoreactivity can be detected within the glomerular 
matrix of the renal corpuscle; however the receptors are present on distinct cell  
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types (57).  Only ET-B receptors are found on endothelial glomerulus cells, whereas both 
types of receptors are present on mesangial cells (57).  Wendel also reported that 
endothelin receptors are located among the renal tubule system, with ET-A receptors 
predominating within cortical collecting ducts and distal tubules and ET-B receptors 
mainly restricted to proximal tubules (57).  Although endothelin receptors are widely 
distributed throughout the nephron, Wendel has postulated that their precise cellular 
location exerts differential effects on renal function (57).  The detailed cellular 
localization of endothelin receptor subtypes were not determined using this 
experimental design; however, future immunofluorescence studies should emphasize 
their distribution. 
While ET-A receptor immunofluorescence staining was observed in each 
experimental group of rats, sedentary male SHR rats had the most intense tubular 
extracellular membrane staining.  This result is consistent with Western blot analysis 
that reported kidney homogenate extracted from sedentary male SHR rats expressed 
the highest level of ET-A receptor expression.  An increase in ET-A receptor staining in 
the renal tissue of sedentary male SHR rats is expected.  As previously noted, ET-A 
receptor expression has been reported to be upregulated in the kidneys of SHR rats 
relative to WKY rats and male rats relative to female rats (55; 83). 
Consistent with Western blot analysis results, ET-B receptor 
immunofluorescence staining was only observed in renal tissue extracted from 
exercised female SHR rats.  This result supports the hypothesis that an upregulation of 
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renal ET-B receptors may be responsible for an increase in sodium excreted in the urine 
of exercised female SHR rats as previously reported by the laboratory of Dr. Penny 
Knoblich (76).   
Levels of Renal and Urinary Endothelin-1  
 The presence of ET-1 in the renal tissue of each group of rats was undetectable 
using Western blot analysis and immunofluorescence microscopy.  These results suggest 
that ET-1 is expressed at a level which was not detectable using this experimental design 
and primary antibody.  However, it has been reported in previous studies that ET-1 is 
expressed in relatively high amounts in the kidneys of WKY and SHR rats (92) .  The lack 
of renal ET-1 expression in both Western blot analysis and immunofluorescence 
microscopy may have been due to an ineffective primary antibody, as both experiments 
utilized the same antibody.  In future studies, Western blot analysis and 
immunofluorescence microscopy could be repeated using antibodies from additional 
sources including the one utilized in the laboratory of Wong. 
ELISA analysis of urinary excretion of ET-1, which is believed to reflect renal ET-1 
synthesis, revealed that the amount of ET-1 was greater in the pooled urine of exercised 
and sedentary male and female WKY rats relative to exercised and sedentary male and 
female SHR rats. This is consistent with previous studies in which a reduction in ET-1 
excretion in hypertensive patients was noted (93).  Patients with essential hypertension 
excrete significantly less ET-1 in their urine compared with normotensive patients (93).  
Due to the natriuretic properties of ET-1, Hoffman has postulated that the reduction in 
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renal ET-1 excretion may be responsible for the development and sustainability of high 
blood pressure in these patients (93).  In similar studies, ET-1 synthesis was reduced in 
the inner medullary collecting duct (IMCD), an area of the kidney in which ET-1 is 
believed to be produced in amounts greater than other tubule segments, of 
hypertensive rats (75; 94).  The renal medulla of SHR rats contains approximately 20% of 
the ET-1 found in the renal medulla of normotensive WKY control rats (94).  Hughes and 
associates have also reported that ET-1 production is reduced in IMCD cells of SHR rats 
relative to age-matched WKY control rats (75).  According to Hughes, ET-1 is responsible 
for preventing sodium and water reabsorption pathways in the IMCD and a reduction in 
renal medullary ET-1 synthesis in SHR rats may contribute to their hypertensive state 
(75), which may explain why a decrease in ET-1 urinary excretion was observed in SHR 
rats relative to WKY rats. 
According to results derived from ELISA analysis, the effect of exercise on urinary 
ET-1 excretion was variable in hypertensive and normotensive rats.  In this study, 
exercised WKY rats excreted more ET-1 relative to sedentary WKY rats and exercised 
SHR rats excreted less ET-1 relative to sedentary SHR rats.  The effect of exercise on ET-1 
excreted in the urine of hypertensive urinary ET-1 excretion was unexpected. In a similar 
study, an increased expression of the ET-1 precursor, preproET-1 mRNA, was detected in 
the kidneys of exercised rats compared to sedentary control rats (64).  An exercise-
induced increase in ET-1 expression is responsible for renal vasoconstriction and the 
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redistribution of tissue blood flow from the kidney to working muscles during endurance 
exercise (64).   
One possible explanation for this anomaly in rats of the SHR strain is the 
presence and effect of increased vascular shear stress. Recent studies have reported 
that an increase in shear stress is associated with hypertension and that endothelial 
dysfunction is increased and shear stress-induced vascular dilation is decreased in SHR 
relative to WKY rats (74; 95).   The long-term application of shear stress to cultures of 
human umbilical vein endothelial cells results in a down regulation of preproET-1 mRNA, 
ECE-1 mRNA, and ET-1 release (49).  Exercise has also been reported to increase vascular 
shear stress (87).  The exercise-induced shear stress added to the inherent shear stress 
of SHR rats is postulated to be the mechanism behind the reduction of urinary ET-1 
excretion observed in exercised hypertensive rats in this study.  A similar effect may not 
be observed in WKY rats because due to their improved endothelial function and lower 
level of vascular shear stress relative to SHR rats. 
The effect of shear stress predominates in animal models of hypertension. This 
may explain why sex was not a determining factor in the amount of ET-1 excreted in the 
urine of SHR rats.  However, in this study female WKY rats were found to excrete 
significantly more ET-1 than their male counterparts.  Males are known to develop 
earlier and a more severe form of hypertension relative to females (96).  Coinciding with 
higher mean arterial pressures, males have also been reported to be inflicted with lower 
levels of endothelial function compared to females (96; 97).  In age-matched healthy 
 103 
 
adults, females have significantly greater flow-mediated dilation than males due to the 
smaller vessel size of females (97).  Increased endothelial function in females may be 
responsible for the higher amount of ET-1 excreted in the urine of female WKY rats 
relative to male WKY rats in this study. 
In ELISA analysis, the amount of ET-1 excreted in the urine of exercised female 
SHR rats was much lower than that of other experimental groups.  Exercised female SHR 
rats had a significantly increased renal concentration of ET-B receptors relative to other 
rat groups.  According to recent studies, ET-B receptors are responsible for the 
clearance of ET-1 from circulation (47).  For example, it has been reported that BQ-788, 
an ET-B receptor antagonist, inhibits the accumulation of intravenously administered 
ET-1 in the lungs and kidneys, thereby slowing its clearance from the circulation (47).  
Treatment with BQ-123, an ET-A receptor antagonist, has been reported to have no 
such effect (47).  Therefore, it is believed that exercised female SHR rats excreted very 
little ET-1 in their urine at least in part due to the upregulation of ET-1 clearance 
resulting from an increased number of renal ET-B receptors. 
Conclusion 
 The purpose of this study was to determine if an exercise induced change in the 
endothelin system is responsible for the increase in sodium excretion in exercised 
female SHR and WKY rats as previously reported by the laboratory of Dr. Penny 
Knoblich.  Because ET-A receptors function in vasoconstriction and sodium retention, it 
was hypothesized that ET-A receptor expression would be decreased in the renal tissue 
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of exercised female SHR and WKY rats relative to sedentary female SHR and WKY rats 
and that exercise will have no effect on ET-A receptor expression in male SHR and WKY 
rats.  Consistent with this hypothesis, Western blot analysis determined that the kidneys 
of exercised female WKY rats had lower ET-A receptor levels compared to sedentary 
female WKY rats.  However, exercised female SHR rats were found to have an increased 
renal ET-A receptor expression relative to their sedentary counterpart and ET-A receptor 
expression was affected by exercise in the case of male SHR and WKY rats.  It was also 
noted that ET-A receptor expression was increased in SHR rats relative to WKY rats and 
male rats relative to female rats, with exercised female SHR rats being the only 
exception. 
 ET-B receptors are responsible for vasodilation and sodium excretion, which is 
why it was initially hypothesized that exercise leads to an upregulation of ET-B receptor 
levels in female SHR and WKY rats and that exercise will have no effect of ET-B receptor 
expression in male SHR and WKY rats.  An increased level of ET-B receptor expression 
was observed in exercised female SHR rats according to Western blot analysis; however, 
this result was not seen in exercised female WKY rats.  In accordance with the 
hypothesis, it was determined that ET-B receptor expression was not mediated by 
physical activity in male SHR and WKY rats. 
 ET-1 mediates vascular changes by activating both ET-A and ET-B receptors; 
therefore, it was hypothesized that ET-1 expression would not vary in the renal tissue of 
male and female rats regardless of physical activity level or strain.  This hypothesis can 
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neither be accepted nor rejected with data derived from Western blot analysis or 
immunofluorescence microscopy because both assays were unable to detect ET-1 
expression. However, ELISA analysis reported varying urinary ET-1 excretion levels in 
each experimental group of rats.  ET-1 excretion was increased in WKY rats relative to 
SHR rats and in females relative to males, with female SHR exercised rats being the 
exception. The greatest amount of ET-1 was excreted in the urine of exercised female 
WKY rats.  Exercise was found to have a variable effect on the amount of ET-1 excreted 
in the urine. 
 In conclusion, exercise induced changes in the endothelin system may be 
responsible for increased sodium excretion levels in exercised female hypertensive and 
normotensive rats as described by the laboratory of Dr. Penny Knoblich.  According to 
Western blot analysis, ET-A receptors are upregulated in the kidneys of exercised female 
SHR rats.  Although ET-A receptors are predominately involved in mediating 
vasoconstriction, a recent study has determined that ET-A receptors also contribute to 
ET-1 dependent natriuresis in female rats (84).  As determined by Western blot analysis 
and immunofluorescence microscopy, ET-B receptors were also upregulated in 
exercised female SHR rats relative to other experimental groups of rats.  ET-1 activated 
ET-B receptors mediate vasodilation and the clearance of ET-1 from systemic circulation, 
which may explain why urinary ET-1 excretion levels were reduced in comparison to the 
other rat groups.  These exercise induced changes in the endothelin system of female 
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SHR rats might be the mechanism behind their previously reported increase in sodium 
excretion levels in response to an artificial rise in mean arterial blood pressure. 
Contradictory to expectations, ET-B expression levels were not increased in the 
renal system of exercised female WKY rats.  However, ET-1 excretion levels were 
determined by ELISA analysis to be the greatest in the urine collected from exercised 
female WKY rats.  Therefore, an increase in ET-1 synthesis in response to exercise may 
explain the increase in sodium excreted in the urine of exercised female WKY rats as 
previously described by the laboratory of Dr. Penny Knoblich.    
Further Studies 
Additional studies are necessary to fully elucidate the effect of exercise on the 
endothelin system of male and female SHR and WKY rats.  To confirm and extend the 
ELISA analysis of ET-1 urinary excretion, urine should be collected and analyzed 
throughout the entire eleven weeks of physical activity instead of the time of euthanasia 
only.  Western blot expression of ET-1 and ET-A and ET-B receptors could be expanded 
and confirmed by characterizing mRNA expression using Northern blot analysis and or 
Reverse Transcriptase-PCR analysis.  Several additional ET-1 primary antibodies should 
be tested using Western blot analysis and immunofluorescence microscopy to evaluate 
ET-1 expression.  Immunofluorescence localization analysis could be correlated with 
differential staining such as hematoxylin and eosin staining to determining the specific 
cellular location of ET-1 and ET-A and ET-B receptors in the vascular and tubular renal 
system of the experimental rats.  Double immunofluorescence staining depicting the 
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colocalization patterns of ET-A receptors and ET-B receptors may be beneficial.  
Quantitative immunofluorescence and a quantitative acquisition software program 
could be also utilized to further immunofluorescence analysis and determine the 
approximate amount of renal ET-1 and ET-A and ET-B receptor expression.   
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